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Malaria and malnutrition remain major causes of morbidity and mortality among 
children under five. The associations between 1) malnutrition and subsequent asymptomatic 
parasitemia or clinical malaria and 2) multiple malaria infections and subsequent growth, were 
assessed among 18,028 visits from 1,182 children 30 months and younger using data from the 
Asembo Bay Cohort Project (ABCP). ABCP was a longitudinal study that collected information 
on children under five from 1992 to 1996 in an intense malaria transmission area of western 
Kenya.  
Infants were enrolled at birth and followed until loss to follow up, death, the end of the 
study, or five years of age. Anthropometric measures and blood specimens were obtained at 
monthly intervals. Anthropometric measures included calculated Z-scores for height-for-age 
(HAZ), weight-for-age (WAZ) and weight-for-height (WHZ). Clinical malaria (parasitemia with 
fever) and asymptomatic parasitemia (parasites without fever) were assessed with thick and thin 
blood films. Multinomial and linear generalized estimating equation models were used to 
estimate odds ratios for the association between malnutrition and malaria outcomes, and 
differences in mean Z-score following a one episode increase in cumulative malaria infection. 
Missing observations were accounted for through a combination of multiple imputation and 
inverse probability weighting.  
Stunting and underweight showed a modest association with subsequent asymptomatic 
parasitemia. The prevalence odds ratios for asymptomatic parasitemia increased from 1.07 
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(0.89, 1.29) to 1.35 (1.03, 1.76) as stunting severity increased from mild to severe, and the 
prevalence odds ratio increased from 1.16 (1.02, 1.33) to 1.35 (1.09, 1.66) as underweight 
increased from mild to moderate. Given the association between malnutrition and 
asymptomatic parasitemia, testing asymptomatic malnourished children for malaria should be 
considered. 
The association between cumulative malaria and malnutrition varied with age. An 
increase in cumulative malaria was associated with a limited decrease in subsequent mean HAZ 
and WHZ among children under 18 months.  Among children 24-30 months, cumulative 
malaria was associated with a limited increase in mean HAZ. Multiple malaria infections may 
lead to consistent diversion and loss of nutrients, resulting in a decrease in subsequent mean 
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CHAPTER 1: INTRODUCTION AND SPECIFIC AIMS 
 
Although malaria and malnutrition remain significant public health issues for children 
under five in the developing world, the relationship between the two remains vague and 
unquantified. This study used epidemiologic methods to investigate the relationship between 
malaria and malnutrition in children under three in Kenya in the mid-1990s. Historically, Kenya 
has had high rates of both malnutrition and malaria. While incidence of both has declined in the 
new millennium, both afflictions remain major contributors to childhood morbidity and 
mortality in Kenya and other parts of Africa. 
The relationship between malaria and malnutrition is challenging to investigate because 
there may be a feedback loop between the two. Malnutrition may increase risk of malaria, while 
malaria may increase risk of malnutrition. It is imperative to use longitudinal data and 
statistical methods that control for time-varying confounding while allowing for the estimation 
of specific causal pathways. In this study we estimated the effect of malnutrition on subsequent 
malaria, and also the effect of malaria on subsequent growth. In both cases, the analytic 
methods minimized reverse causality and controlled for time varying confounding affected by 
prior exposure. 
The term malnutrition refers to a condition of poor growth and small body size resulting 
from frequent infections combined with inadequate intakes of protein, energy, and 
micronutrients. Malnutrition can weaken the immune system’s ability to prevent and respond to 
disease, resulting in increased duration and severity of disease, and increased risk of death. We 
hypothesized that children who experience malnutrition potentially face a greater risk of malaria 
infection or malaria severity. This study utilized a rich dataset to investigate whether the 
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incidence or prevalence of asymptomatic parasitemia or clinical malaria was associated with 
prior malnutrition among children under three years of age in western Kenya.  
Malnutrition has also been shown to follow episodes of infection, namely diarrhea and, 
to a more limited extent, respiratory infections. The impact of malaria on children’s growth has 
not been well quantified. This study also quantified the cumulative effect of malaria on 
subsequent children’s growth.  
 
Specific Aim 1:  
Investigate the association between malnutrition and the odds of both prevalent and 
incident asymptomatic parasitemia and clinical malaria among children from birth through 30 
months in rural Kenya. 
Hypothesis: Malnutrition will be associated with higher odds of both incident and prevalent 
clinical malaria and asymptomatic parasitemia.  
Methods: A longitudinal cohort following children from birth through 30 months was  
analyzed using marginal structural, multinomial, generalized estimating equation (GEE) 
models. These models allowed for estimation of odds ratios, while controlling for time varying 
confounding affected by prior exposure and accounting for repeated measurements. 
Exposure: The exposure was categorized Z-score, calculated for three different 
anthropometric indices: height-for-age (stunting), weight-for-age (underweight) and 
weight-for-height (wasting). 
Outcome: Both incident and prevalent malaria were investigated as outcomes. For each, 
a repeated measure, three-level, ordinal categorical variable was used, indicating:  1) no 
parasitemia 2) asymptomatic parasitemia 3) clinical malaria (presence of parasites with 
fever).  
Model: The marginal structural, multinomial GEE model investigated the effect of Z-
score category on malaria outcomes measured one month after the exposure. A different 
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model was used for each type of nutritional index, and each type of outcome (incidence 
and prevalence). Each model provided estimates for odds ratios comparing odds of 
malaria incidence or prevalence among children with severe, moderate, mild, or 
overweight – stunting, underweight or wasting – to those with no stunting, underweight 
or wasting.  
Missing Data and Selection Bias: Due to a large amount of non-monotone missing height 
and weight data, missing Z-scores and other missing covariate data from kept visits were 
imputed using multiple imputation. Additionally, there was a potential for selection bias 
due to dropout or missed visits. Inverse probability weights were used to correct for this 
potential selection bias. 
Rationale: The effect of malnutrition on subsequent malaria remains unclear. Pinpointing 
children who are most at risk of malaria would allow malaria prevention programs to target 
limited services and supplies to those who may benefit the most, reducing costs and ensuring 
scarce resources are used as effectively as possible.   
 
Specific Aim 2:  
Estimate the cumulative effect of malaria on height-for-age, weight-for-age, and weight-
for-height Z-score in children ages 0-30 months in rural Kenya. 
Hypothesis: An increase in cumulative episodes of incident clinical malaria or months with 
either prevalent clinical malaria or prevalent parasitemia will be associated with a decrease in 
population mean Z-scores. 
Methods: A longitudinal cohort following children from birth through 30 months was  
analyzed with linear marginal structural GEE models that allowed for estimation of cumulative 
effects, while controlling for time varying confounding affected by prior exposure, and 
accounting for repeated measurements.  
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Exposure: Three different exposures were investigated – cumulative episodes of incident 
clinical malaria, cumulative months with prevalent clinical malaria, and cumulative 
months with prevalent parasitemia. Clinical malaria was measured as any parasitemia 
with fever, and considered an incident infection if the previous month showed no 
parasites. 
Outcome: Height-for-age, weight-for-age, and weight-for-height Z-scores were used as 
outcomes. The outcomes were measured in the visit following the exposure 
measurement.  
Model: Linear marginal structural repeated measures GEE models were used. These 
provided estimates of the effect of one additional episode of incident clinical malaria, 
month of prevalent clinical malaria, or month of prevalent parasitemia exposure on 
population mean Z-score. The models were weighted by inverse probability of exposure 
weights to account for time varying confounding affected by prior exposure.  
Missing Data and Selection Bias: Due to a large amount of non-monotone missing height 
and weight data, and potential selection bias due to dropout or missed visits, inverse 
probability of observation and censoring weights were combined with multiple 
imputation to address potential bias due to dropout and missing data. 
Rationale: The cumulative effect of falciparum malaria on growth is complex and has rarely 
been quantified. Multiple malaria infections or persistent parasitemia in children may lead to 










CHAPTER 2: BACKGROUND AND SIGNIFICANCE 
 
Summary 
Malaria and malnutrition are two commonly occurring co-morbidities in the developing 
world whose most dire consequences mainly affect children under five. While previous research 
has made great strides in understanding the causes and effects of both afflictions, the 
relationship between the two has not been sufficiently quantified. The cyclical nature of the 
relationship makes epidemiologic research on this topic challenging. Malnutrition may increase 
risk of malaria, while malaria may increase risk of malnutrition. Longitudinal studies and 
analyses that minimize reverse causality bias while controlling for time varying confounding are 
needed to investigate this relationship. The use of marginal structural models (MSM) to adjust 
for time varying confounding affected by prior exposure makes this study a novel addition to the 
literature on malaria and undernutrition. A significant association between undernutrition and 
malaria would allow practitioners to advocate for better integrated treatment and prevention 
programs where high risk children could be monitored and treated or enrolled in a prevention 
program for either malaria or undernutrition.  
Background 
Malaria remains a primary cause of morbidity and mortality among 
children under five. In Africa it was the fourth leading cause of death in this age group in 
2015,1 with one child dying every two minutes from malaria.2 The burden of malaria is difficult 
to quantify because many infections and deaths from malaria go unreported. According to the 
World Health Organization (WHO), in 2017 there were approximately 219 million cases of 
malaria and 435,000 deaths, mainly among African children.2 According to the Institute for 
Health Metrics and Evaluation, there were between 170 and 258 million cases of malaria in 
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2017, and 440,000 to 840,000 deaths.3 Malaria can cause severe morbidity in children such as 
anemia, epilepsy, neurological disorders,4 and impaired locomotion.5 All forms of malaria, from 
asymptomatic parasitemia to severe disease, have been shown to reduce cognitive abilities.6–12 
Cerebral malaria may result in long term neurological sequelae including: 
hemiplegia/hemiparesis (weakness in one or both limbs on one side of the body), speech 
disorders, behavioral disorders, blindness, hearing impairment, cerebral palsy and epilepsy.13 
Although progress in malaria control has been made, much of the world remains at risk 
and malaria research, prevention and control programs must continue to ensure malaria 
reduction targets are met. Malaria incidence has been reduced by 40%, while prevalence was 
reduced by half between 2000 and 2015 in Africa.14 Despite this success, in the past malaria 
control programs have been underfunded, delaying progress in the most affected countries.2 
According to the most recent World Malaria Report, gains in malaria control stalled between 
2015 and 2017, and 13 countries saw an increase in malaria infections in 2017.2 Almost half of 
the world’s population remains at risk of malaria. The majority are in sub-Saharan Africa, yet 
other regions are also at risk. In 2017, 90 countries and territories had continuing malaria 
transmission.2 Parasite resistance to artemisinin, the current front line treatment in most of the 
world, has been detected in four Southeast Asian countries. Mosquito resistance to pyrethroids, 
the only recommended insecticide used for insecticide treated nets (ITNs), has emerged in both 
sub-Saharan Africa and India.2 Rising temperatures due to climate change are also likely to 
increase malaria incidence, especially in high altitude regions where malaria is currently limited 
by low temperatures.15 Climate change and continued parasite and vector evolution have the 
potential to derail recent achievements in malaria control and prevention, and increase the 
number of individuals at risk of malaria, as shown by the recent global increase in malaria 
incidence.2 
A large proportion of malaria infections, especially in highly endemic areas, are 
asymptomatic.16,17 Most asymptomatic infections go untreated, yet the effect they may have on 
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other adverse health conditions remains unclear. Associations with anemia, thrombocytopenia 
and cognitive function have been shown. In children, asymptomatic malaria may contribute to 
low grade inflammation, lower hemoglobin and platelet counts.17 Additionally, some 
asymptomatic infections may serve as a reservoir for continued malaria transmission.18 
Due to the continued high burden of malaria in children under five, further research on 
risk factors and effects of malaria is warranted. Despite reductions in malaria morbidity and 
mortality over the past 20 years, malaria continues to pose a threat to child survival, causing a 
significant proportion of illness and deaths in children under five in Africa. Pinpointing children 
who are most at risk of malaria will allow malaria prevention programs to target limited services 
and supplies to those who may benefit the most, reducing costs and ensuring scarce resources 
are used as effectively as possible. Targeting children who have suffered from multiple malaria 
infections for additional services may help to prevent downstream effects of malaria.  
Malnutrition continues to afflict a high proportion of children under five 
worldwide, especially in malaria endemic regions, despite advances in the treatment and 
prevention of moderate and severe acute undernutrition since the 1970s. Worldwide, almost 
every country has a level of malnutrition that can be considered a serious public health risk.19 In 
2017, 150 million children (22%) under the age of 5 globally were estimated to be stunted,  50 
million (7.5%) were wasted, and 16 million (2.4%) were severely wasted.20  
While malnutrition refers to poor nutritional status at both ends of the spectrum (under 
nutrition as well as overweight and obesity), undernutrition continues to make up the majority 
of malnutrition cases in Africa.21 Poor growth in children can result from both inadequate food 
intake (resulting in any combination of inadequate energy, protein and micronutrients) and 
infections and disease. In this study, we were interested in studying the effects of poor growth 
that result from both inadequate food intake and frequent infections. We use the terms 
malnutrition or undernutrition to refer to the syndrome of inadequate intake of protein, energy 
and micronutrients combined with frequent infections that result in poor growth.22 Malnutrition 
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is measured with three different nutritional indices: weight-for-age (underweight), 
length/height-for-age (stunting) and weight-for-length/height (wasting). A low Z-score for any 
of these indices is considered a marker of malnutrition. In general, length is measured for 
children under two years while height is measured for children two years and older. Going 
forward we will refer only to height, but for children under two we assume length was measured. 
The African region has not made the same strides as the rest of the world in 
reducing malnutrition. Globally, stunting, underweight and wasting were reduced by 35%, 
36% and 11%, respectively, between 1990 and 2011. In Sub-Saharan Africa, however, 
underweight was only reduced by 8% during this same period, leaving this region short of the 
15% reduction target set by Millennium Development Goal #1.23 Between 2000 and 2017, Africa 
was the only region where the number of stunted children actually increased (from 51 to 59 
million).20 East Africa and Kenya have particularly high burdens of suboptimal growth. Over one 
third (36%) of all children in East Africa are stunted.20 In Kenya alone, almost 2 million (26.2%) 
children under age 5 were stunted in 2014 and more than a quarter million (4%) were wasted.20 
Undernutrition in childhood has both short term and long term effects. The 
immediate consequences of malnutrition include: an increase in both duration and severity of 
infectious disease, increased risk of mortality, and decreased physical activity.22 Taken together, 
all forms of undernutrition (fetal growth restriction, suboptimal breastfeeding, stunting, 
wasting, and micronutrient deficiencies) cause 45% of child deaths globally, resulting in an 
estimated 3.1 million deaths per year.21 In the long term, children with malnutrition also face 
earlier onset and increased risk of non-communicable diseases, impaired cognitive 
development,24 increased incidence of depression,19 decreased school attainment,25,26,27 and 
forgone wages and decreased labor productivity.28  
Current programs and policies are insufficient to reach nutrition goals set 
by the World Health Assembly in 2012. The World Health Organization (WHO) and 
UNICEF project that none of the six World Health Assembly nutrition targets will be reached by 
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2025. These include reducing by 40% the number of children under 5 who are stunted and 
reducing and maintaining childhood wasting to less than 5%.29 Progress towards these goals 
depends not only on the extent of current programs and policies, but also on external factors 
such as climate change, conflict, trade, financial upheavals and political leadership.30 
Malnutrition affects a large proportion of children in malaria endemic regions, and may 
alter susceptibility to malaria, and/or be induced by multiple malaria infections. The cyclical 
nature of the relationship between malaria and malnutrition, as shown in Figure 1, makes 
research on this topic challenging. Malaria may be both a result of malnutrition and a cause of 
malnutrition, while malnutrition may increase malaria susceptibility or result from one (or 
many) malaria infections. A cross sectional study design would not be able to indicate which 
came first, malaria or malnutrition. By using a longitudinal design, along with analytic 
techniques that prevent confounding by a previous outcome, this study contributes 




Figure 1: Directed Acyclic Graph for the relationship between malaria and malnutrition 
 
Research on malaria as both an effect and contributing risk factor for malnutrition may 
help practitioners to meet global nutrition goals by enabling targeted programming to additional 
children at risk of undernutrition. This research could also be a catalyst for developing programs 
to mitigate the effects of poor growth. 
Studies on the effects of malnutrition on malaria also need to consider potential 
confounding by anemia, which is often a co-morbidity to both. Malnutrition and anemia can 
10 
have a common cause (poor nutrition or illness) and iron deficiency anemia (IDA) has been 
shown to protect against malaria.31,32 Over 40% of all preschool aged children in developing 
countries are estimated to have anemia.33 In Africa specifically, the prevalence increases to over 
60%, affecting over 80 million children.33 In Kenya, 69% of preschool aged children were 
estimated to be anemic in 1999,33 and the most recent DHS survey indicates that only 33% of 
children under age 5 consumed iron rich foods in the previous 24 hours and only 6% were given 
iron supplements in the preceding 7 days.34 The most common cause of anemia globally is iron 
deficiency,35 but it can also result from other forms of poor nutrition (vitamin B12, vitamin A, or 
folate deficiencies) or infections such as malaria or hookworm. In populations that experience 
concurrent malnutrition and IDA, studies investigating the association between malnutrition 
and malaria may be influenced by the presence of IDA. When studying the effects of 
malnutrition on malaria, it is important to include iron deficiency as a confounder in the model, 




Suboptimal nutrition and associated poor growth may weaken the immune 
system and prevent a child from mounting an adequate immune response against 
malaria. Undernutrition is known to significantly increase risk of death in children under 
five,36–38 and may also lead to more frequent and chronic infections.39 Undernutrition can impair 
both the innate and adaptive immune response.40 Within the innate immune system, macro and 
micronutrient deficiencies decrease cytokine production, and reduce phagocyte and natural 
killer cell functioning. Undernutrition may also decrease T lymphocytes, impeding the adaptive 
immune response.41,42 Both innate and adaptive immune systems are involved in the immune 
response to malaria. The innate immune system limits parasite density, while the gradually 
acquired adaptive immune response works to remove the parasite.43 An underperforming 
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immune system that develops from undernutrition may therefore result in more frequent 
and/or more severe malaria infections. 
There are numerous previous studies that have investigated the effect of 
undernutrition on malaria, however most have methodological limitations and the 
results are inconsistent. There have been 20 cross sectional studies on the relationship 
between undernutrition and malaria. Eleven of these found that some form of undernutrition 
(generally either stunting, wasting or underweight, but food insecurity,15 mean weight44 and 
mid-upper arm circumference (MUAC)45 were also investigated) was associated with an 
increased risk of malaria (defined as presence of malaria parasitemia,15,46,47 presentation with 
clinical malaria45,47–49 community incidence of malaria,50 severe malaria sequelae,44,48,51,52 or 
immune response to malaria53). Seven studies found that undernutrition was protective against 
malaria,15,51,54–58 and six found no association.46,50,59–62 Many early clinic and hospital based 
studies suggested that poor nutritional status may be protective against malaria infection.54,55,63–
65 Most of the recent hospital based studies, including one in Kenya62, have suggested that 
among those admitted to the hospital for malaria, patients who are malnourished are more 
likely to die.44,48,58,66,67 In contrast, two recent hospital based studies in India54and Thailand57 
indicated that better nutrition increased risk of parasitemia and severe malaria sequelae, 
respectively. The cross-sectional and hospital based studies are limited by their simultaneous 
assessment of malaria and nutritional status. Because the effects of undernutrition on malaria 
may be cyclical (with undernutrition contributing to an increased risk of malaria, and malaria 
potentially leading to increased risk of undernutrition) any study that measures both at the 
same time may suffer from reverse causality bias. To minimize the potential for this bias and 
assess a causal relationship between undernutrition and malaria, a longitudinal study is needed.  
There have been nine longitudinal studies on the effect of undernutrition on 
malaria, also with inconsistent results (see Table 1). Two studies found a positive 
association between stunting and malaria incidence,68,69 while two others found a negative 
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association between wasting70 or stunting71 and malaria incidence. Most found no statistically 
significant association between undernutrition and malaria.70,72–76 However, all of these studies 
had significant limitations. Three had small samples of less than 400 children.69,71,73 The 
majority were limited by their specification of malnutrition as a time fixed exposure,68–71,73,74 
when in reality, anthropometrics indicating malnutrition may change over time. Only three 
studies used time varying exposures,72,75,76 while the remainder either used anthropometric 
measurements at baseline only, or mean Z-score for the study period.69 The three studies that 
did use time varying exposures may also be inadequate, due to their failure to use a marginal 
structural model (MSM) to account for time varying confounding affected by prior 
exposure.72,75,76 No studies have used inverse probability of exposure weights to control for time 
varying confounding affected by prior exposure. Only three previous studies investigated the 
association of malnutrition with asymptomatic parasitemia, also with inconsistent results (see 
Table 2).59,71,77 Lastly, most studies have focused on the effect that malnutrition may have on 
malaria incidence, but none have compared how this estimate may differ from the effect that 
malnutrition may have on prevalence.  
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Table 1: Summary of longitudinal studies on the association between malnutrition and subsequent 
malaria 












































1.19 (1.01, 1.40) 





9 – 24 
months 




0.71 (0.28, 1.14) 










1.35 (1.08, 1.69) 
1.01 (0.82, 1.26) 
0.87 (0.69,  1.10) 
Risk ratio 























No effect for any 
parasites 
IRR for malaria: 






6 weeks to 
12 months Malaria incidence 
Stunting  
Underweight 
1.24 (1.03, 1.48) 













0.96 (0.65, 1.41) 
1.24 (0.96, 1.59) 
Hazard 
ratio 
IRR = incidence rate ratio; NS = not significant (this generally meant results were not reported, other than to say they 
were not significant).  
*Pooled nutrition status indicates that children who had a z-score of < -2 in any category were considered 
“malnourished” and counted as the exposed group. 
**Included estimates for P. falciparum which are reported here. 
Stunting, underweight, and wasting were all defined as Z-score < -2. 




Table 2: Summary of studies on the association between malnutrition and subsequent asymptomatic 
parasitemia 
Study Location Age 
Exposure 









1.13 (0.98, 1.29) 




201059 Ghana < 5 years Stunting 0.56 (0.16, 1.69) 
Odds Ratio 
Akiyama 
201677 Laos < 10 years Stunting 3.34 (1.25, 8.93) Odds Ratio 




Multiple malaria infections may reduce growth by altering intake, 
absorption and use of nutrients due to chronic inflammation. Numerous severe 
infectious diseases in childhood have been shown to cause acute wasting and affect linear 
growth. These include diarrhea, pneumonia, measles, meningitis and malaria.21 Less severe 
forms of disease may also impair growth by suppressing appetite, reducing nutrient absorption, 
increasing nutrient losses and diverting nutrients to fight infection.78,79 Children who suffer a 
single bout of infection may recover without any significant loss of growth, or they may 
experience catch-up growth after recovery, provided they have an adequate nutritional intake 
and no immediate additional infections.79 However, children who experience multiple bouts of 
infection or persistent subclinical infection may be put into a state of continual growth 
suppression.78 We hypothesized that multiple malaria infections or persistent parasitemia in 
children may lead to consistent diversion and loss of nutrients, contributing to growth faltering 
and sustained undernutrition. 
Most previous research has shown that malaria leads to growth deficits in children, 
either in weight gain (underweight) or height (stunting). Three studies from the 1970s found 
that malaria was associated with decreased weight gain,80–82 while one ecologic study found no 
difference in nutritional status between children in low and high malaria incidence areas.83 A 
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more recent cross sectional study found that malaria was an independent predictor of 
stunting.84 One early intervention study looked at the effect of indoor residual spraying (IRS) 
and mass drug administration (MDA) with sulfadoxine/pyrimethamine (SP) on nutritional 
status, and found that children in treatment villages had slightly better anthropometric 
measurements.85 There have also been six ITN intervention studies, five of which demonstrated 
that children who lived in ITN receiving villages showed higher weight gain and better 
nutritional status than children in control villages.86–89 The remaining ITN intervention study 
concluded that ITNs did not have a significant impact on nutritional status.90 Most of the early 
studies, and especially the ecologic and cross sectional studies, measured malaria and 
nutritional status at the same time, thus subjecting them to potential reverse causality bias. The 
later intervention studies clearly show a relationship between the use of ITNs and improved 
nutritional status. However, these studies are measuring the impact of the ITN intervention, 
which may protect against other infections in addition to malaria, and do not quantify how 
multiple malaria episodes may directly affect nutritional status and growth. The only study that 
has investigated the effect of asymptomatic parasitemia on weight, height and BMI outcomes 
among children and adolescents showed no effect on any of these outcomes.91 
The six recent longitudinal studies that have investigated the effect of 
malaria on growth have had mixed results and limitations (See Table 3). A 1997 study 
in Vanuatu found an inverse association between P. vivax and nutritional status, but no 
association for P. falciparum.74 A 2012 study found that one episode of P. vivax malaria led to 
less weight gain and lower stature in children under 6.92 Two longitudinal African studies in 
Ghana and Kenya also found a positive relationship between malaria incidence and underweight 
and stunting. Unfortunately, both these studies may also be subject to reverse causality. The 
Kenyan study measured anthropometry infrequently, making it difficult to determine when 
growth faltering may have begun and leaving open the possibility that undernutrition may have 
occurred before or during malaria.93 The Ghana study measured malaria as a time varying 
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exposure but did not adjust for time varying confounding affected by prior exposure.75 Another 
recent study in Kenya found decreased growth among children under 3 years associated with 
malaria parasitemia.94 This study also used a time varying exposure but did not control for time 
varying confounding and may be subject to confounding bias. Of all the previous studies on this 
topic, only one has sufficiently controlled for confounding and eliminated the potential for 
reverse causality bias. A 2013 study in Ghana used Mendelian randomization to control for 
confounding and found that with every 1 unit increase in malaria, there was a 0.32 increase in 
risk of stunting.95 Given that only one previous study on malaria and growth in children has 
appropriately controlled for confounding and potential reverse causality bias, additional studies 
are needed to contribute to the knowledge of how malaria contributes to undernutrition and 
growth faltering, and to quantify how large the effect is. There have been few longitudinal 
studies that have investigated the effect of any parasitemia on growth.75,84,94 
 
Table 3: Summary of longitudinal studies on the association between malaria and subsequent growth 




















200493 Kenya < 8 years Clinical malaria 
Stunting 
Underweight 
1.89 (1.01, 3.53) 





6 to 24 
months 
Any parasitemia 
Clinical malaria  
 
HAZ AP: -0.17 (P=0.02) CM: -0.18 (P=0.01) 
Difference 
in mean  
Kang 201395 Ghana 3 to 24 months 
Number of 




















-0.02 (-0.04, -0.008) 
0.05 (0.009, 0.09) 
0.07 (0.02, 0.12) 
Difference 
in mean  
AP = any parasitemia CM = clinical malaria; NS = not significant (this generally meant results were not reported, 
other than to say they were not significant).  
*included estimates for P. falciparum, which are reported here. 




A better understanding of the relationship between malnutrition and malaria may be an 
indicator for integrated treatment and prevention programs. Malnutrition and malaria are often 
co-occurring conditions, yet prevention efforts are not always coordinated or simultaneously 
implemented. The marginal benefit of adding a nutrition component to an existing malaria 
prevention program or vice versa may be larger than expected, if the nutrition component also 
prevents or ameliorates malaria morbidity, or if malaria treatment and prevention helps to 
prevent growth faltering. A causal relationship between malaria and malnutrition would also 
highlight the benefit of integrated treatment programs. Children receiving treatment for 
malnutrition may benefit from intermittent presumptive therapy, or active monitoring for 
malaria infection. Likewise, children who have suffered from multiple malaria infections may 
benefit from supplementary food to prevent stunting and underweight or they may also warrant 
more active monitoring for growth faltering. 
Aim 1 investigates the association between malnutrition and subsequent malaria and 
asymptomatic parasitemia incidence and prevalence. This research contributes to the literature 
on the interrelationships between malaria and malnutrition. It also highlights the potential 
effects of malnutrition on asymptomatic parasitemia incidence and prevalence, which has rarely 
been investigated. Currently, asymptomatic parasitemia is not generally treated, although it can 
have negative effects and can potentially serve as a reservoir for malaria transmission.17,18 If 
malnourished children are at greater risk for asymptomatic parasitemia, this could be an 
indication for treating malnourished children, either presumptively or after testing, to reduce 
potential malaria reservoirs among already malnourished and weakened populations and 
prevent downstream effects of asymptomatic infections such as anemia and low grade 
inflammation.  
Aim 2 investigates the effects of multiple malaria infections and cumulative parasitemia 
on weight and height Z-scores in children. Currently, malaria treatment programs do not 
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provide supplementary food. If children suffering from multiple bouts of malaria or 
asymptomatic parasitemia are at higher risk for undernutrition, they could be referred to 
supplementary feeding programs, or provided with supplementary foods as an integral part of 
their malaria treatment. This may prevent stunting or weight loss that occurs as a result of 
multiple malaria episodes or prolonged parasitemia. There is some evidence to suggest that 
nutrition interventions can reduce or eliminate the effect of diarrheal disease on child growth.78 
Should malaria also contribute to reduced growth in children, nutrition interventions may be 
warranted.  
Innovation 
This study is an innovative addition to the literature on malaria and nutritional status for 
two reasons. 1) The use of an older dataset allows for analysis of a population who experienced 
more malaria episodes than a current population would encounter. The higher incidence of 
malaria gives the study more power to investigate causal associations than a current day study 
would have with the same sample size. 2) The majority of previous studies have been 
methodologically limited by the potential for reverse causality bias and time-varying 
confounding affected by prior exposure. This study used marginal structural models to estimate 
multi-directional associations between malnutrition and malaria. 3) Most previous studies on 
the relationship between malnutrition and malaria have focused on clinical malaria. By 
investigating clinical malaria, asymptomatic parasitemia and cumulative parasitemia this study 
provides an innovative addition to the literature on this topic. 4) Most previous studies have 
focused on how malnutrition may affect malaria incidence. By comparing the effects of 
malnutrition on incidence and prevalence, this study provides an indication of whether 
malnutrition places children at higher risk of more frequent infections, longer durations of 
infection, or both. 
Research on the relationship between malaria and malnutrition is 
methodologically difficult for the following reasons:   1) Malaria may increase risk of 
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malnutrition, while malnutrition may also increase susceptibility to malaria. To effectively 
determine a causal relationship in either direction, while ruling out the potential for reverse 
causality, one must utilize a longitudinal design and appropriate statistical analysis. 2) When 
studied over time, a single individual may have multiple episodes of malnutrition and/or 
malaria. This must be accounted for through the use of analytic methods that allow for time 
varying exposures and repeated outcomes. 3) When assessing causal effects between time 
varying exposures and repeated outcomes, it is important to account for time varying 
confounding by both previous outcomes and exposures, and other potential confounders in the 
model. 4) There may be a cumulative effect of malaria on growth, which should be accounted for 
in the analysis. While a child may be able to recover from a failure to gain weight or height 
resulting from a single bout of malaria, the loss in weight gain and height resulting from 
multiple malaria episodes or prolonged exposure to parasitemia may be more difficult to recover 
from.  
Almost all previous studies on this topic have been methodologically limited by their 
failure to account for the above mentioned difficulties. This study will improve upon previous 
work through: 1) The use of marginal structural models to account for time varying confounding 
affected by prior exposure 2) The inclusion of non-malarial anemia as a proxy for IDA, to 
account for confounding of the relationship between malnutrition and malaria by IDA; 3) The 
analysis of cumulative effects of malaria on weight and height in Aim 2. None of these 
methodologies have ever been used to study this relationship before, and as such, they make this 









CHAPTER 3: APPROACH 
 
Study Overview 
Data Source and Study Population 
Data for this study come from the Asembo Bay Cohort Project (ABCP), a study conducted 
in 15 villages in the Asembo Bay area of Siaya District in Nyanza Province, western Kenya 
between 1992 and 1996. The study was designed to assess the epidemiology, entomology, 
immunology, host factors, molecular biology, antigenic variation, and population genetics of P. 
falciparum in a large cohort of women and children in an area with intense malaria 
transmission. Malaria was holoendemic in the study site, with an estimated entomologic 
inoculation rate of 0.75 infective bites per person per day.96 Beginning in June 1992, all 
pregnant women in participating villages were identified during a monthly census by trained 
community health workers or birth attendants residing in the same village. They provided 
informed consent and were visited every month at home by village monitors who administered 
standard questionnaires and obtained axillary temperatures, thick and thin blood smears and 
capillary blood samples. Mother-infant pairs were visited within two weeks of birth and then 
every 2 weeks thereafter. Direct siblings under 15 were also enrolled. At each visit 
questionnaires were administered and the children’s health was reported by the mother or an 
adult sibling or guardian. Height and weight were measured in centimeters and kilograms 
(respectively) to the nearest 10th. Children who were old enough to stand were measured 
standing, all others were measured recumbent. Axillary temperatures were obtained using a 
digital thermometer and capillary blood and thick and thin blood smears were collected once per 
month. Any participant with documented fever and malaria parasitemia received a treatment 
dose of sulfadoxine/pyrimethamine.  More severe illnesses were referred to local health 
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facilities, where chloroquine was the only treatment available for malaria. Mother-infant pairs 
and siblings under five were followed until they were lost to follow-up, end of the study, or the 
infant or sibling’s fifth birthday.97 
All blood smears were stained with Giemsa and parasite densities were quantified by 
counting the number of asexual parasites per 300 leukocytes. Parasite density was calculated 
assuming a leukocyte count of 8,000/mm3. Hemoglobin was measured using the HemoCue 
system (HemoCue, Anglholm, Sweden).98 Hemoglobin genotyping was done retrospectively 
using a polymerase chain reaction method.99 Additional information regarding laboratory 
procedures and data collection has been described in the literature.97 
 
Study timeline and sample size 
There were 1,660 children enrolled in the study. Children were followed for 15 months, 
on average (median = 12). Age at entry ranged from 0 to 32 months, with the majority of 
children (87%) having their first visit within one month of birth. 98% of the children had their 
first visit within 3 months of birth. 168 children were missing follow-up data and 84 children 
were missing age or sex data were excluded. This reduced the sample size to 1,408. The dataset 
for this study was limited to children under 30 months, when less than 20% of the original 
sample remained. This further reduced the dataset by 1, to 1,407 children. Finally, the dataset 
was limited to the first child enrolled from each mother, removing an additional 225 children, 
leaving a final sample size of 1,182 children.   
 
Analysis Plan 
Aim 1 Analysis 
In Aim 1 we investigated the association between malnutrition and subsequent clinical 
malaria and asymptomatic parasitemia incidence and prevalence among children from birth 
through 30 months. 
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Causal Diagram 
A basic directed acyclic graph (DAG) showing the time varying nature of the exposure, 
the outcome, and time varying confounders is shown below. A full DAG showing all potential 
confounders is shown in Appendix A. Covariates to be adjusted for in the model have been 
chosen from this DAG analysis. The chosen covariates will block all backdoor paths between the 
exposure and the outcome, except for those paths for which there are no data on confounders. 
 
 
Figure 2: Directed Acyclic Graph for Aim 1 - Time Varying Variables 
 
Figure 2 presents a DAG showing the relationship between Z-score and malaria at 
different time points. U indicates unmeasured confounders that may induce a relationship 
between malaria at different time points (examples are unmeasured structural or environmental 
conditions in the home that may prevent or increase mosquitoes – such as standing water). Blue 
lines indicate effects we wish to estimate. Boxed variables indicate confounders that will be 
adjusted for in the analysis. Red lines indicate problematic associations that will be removed 
through the use of inverse probability of exposure weights. Dashed lines indicate indirect 





Main Exposure variable – Growth faltering 
There are two types of malnutrition, stunting (defined as low height-for-age) and wasting 
(defined as low height-for-weight). Stunting represents a chronic condition and occurs as a 
result of inadequate nutrition over time, while wasting represents an acute condition and occurs 
as a result of recent rapid weight loss or a failure to gain weight. Underweight (defined as low 
weight-for-age) is the most commonly used nutritional index, but it actually represents a 
combination of children who have low weight because they are short (stunted) and those who 
are underweight because they are thin (wasted). We used all three indexes (stunting, wasting, 
and underweight) as exposure variables.  
Weight, height and age data were used to calculate a Z-score for each anthropometric 
index. The Z-score indicates the child’s standard deviation from the mean in comparison to a 
reference population. WHO’s Multi Centre Growth Reference Study was used as the reference 
population.100 Z-scores that were outside plausible bounds were flagged and discarded, 
according to the following guidelines defined by WHO: Weight-for-age Z-score (WAZ) less than 
-6 or greater than 5; Height-for-age Z-score (HAZ) less than -6 or greater than 6; Weight-for- 
height Z-score (WHZ) less than -5 or greater than 5.  
Plausibility of height measurements was also assessed visually. A method to visually 
assess plausibility of length and height measurements was defined based on previously 
described methods.101 Height for each child was graphed over time and flagged for visual 
inspection if it indicated a decrease from the previous measure of more than two centimeters. 
Flagged heights that appeared as a "divot," deviating from the height trend, were discarded if the 
following point returned to the original height trend. The previous height was discarded if it 
appeared as a “peak,” where it deviated above the height trend, and the following height 
returned to the original trend. The last height measurement on a child was not flagged for 
missing unless it was clear there was a loss of height from a consistent height trend in the 
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previous measurements. If no immediate trend could be seen in the measurements before or 
after the flagged height, the flagged measurement remained in the data.  
Rapid weight gain and loss are plausible in children due to illness or catch-up growth 
post illness. Therefore it was difficult to accurately assess whether weight data were potentially 
mismeasured. We only relied on the WAZ and WHZ flags to exclude potentially mismeasured 
weight data.  
Outcome variable - Malaria 
Both prevalent and incident malaria were investigated as outcomes. A repeated measure, 
three-level, ordinal categorical variable was created indicating: 1) no parasitemia; 2) 
asymptomatic parasitemia (presence of parasites without fever); and 3) clinical malaria 
(presence of parasites with fever - axillary temperature ≥ 37.5°C). For prevalent malaria the 
entire sample was included in the analysis and both asymptomatic and clinical malaria were 
defined as the presence of parasites with (clinical), or without (asymptomatic) fever in the 
month following the exposure, regardless of the child’s current malaria status.  
For incident malaria, the sample was restricted to visits with a negative blood film 
concurrent to the nutritional exposure measurement, limiting the population to children who 
could be at risk for an incident infection in the following month. Incident asymptomatic 
parasitemia and incident clinical malaria were then defined as the presence of parasites with 
(clinical) or without (asymptomatic) fever in the month following exposure, among children 
with a current negative blood film. 
Covariates 
Covariates that were included in the model as confounders included: season, mother’s 
education, socioeconomic status (SES), infant age (time), residence, non-malarial infection, 
non-malarial anemia, maternal peripheral parasitemia at delivery, and sickle cell genotype. All 
confounders were identified from a DAG analysis (see Appendix A).   
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Time varying covariates included season, infant age (time), non-malarial infection and 
non-malarial anemia. Season was categorized into rainy, dry, and transition periods and coded 
as indicator variables. There were two rainy seasons from March to May and October to 
December, and two dry seasons from January to February and June to September. An infection 
variable was derived and defined as dichotomous variable indicating presence of any of the 
following in the absence of malaria parasitemia: inability to drink, experience of chills, diarrhea, 
vomiting, difficulty breathing, or fever. Time was included in the model and calculated as 
months from birth (the origin). This ensured infants of the same age were being compared. 
Covariate – Non-Malarial Anemia 
Ideally, this study would have controlled for confounding by iron deficiency anemia. 
Unfortunately, ABCP did not collect data on iron status, but data on hemoglobin concentration 
was available. Low hemoglobin concentration was used as a proxy for iron deficiency status. 
Anemia is considered a non-specific biomarker for iron deficiency.102 However, anemia can also 
be caused by malaria or other infections, or by sickle cell disease. Sickle cell genotype was 
controlled for in the analysis. We also differentiated between malarial anemia and non-malarial 
anemia as described below. By controlling for these two main additional causes of anemia 
(sickle cell disease and malaria), we increased the specificity of hemoglobin as a biomarker for 
iron deficiency. 
Anemia can be both protective against malaria and caused by malaria, which makes it a 
difficult variable to work with in this study. Anemia that is caused by malaria should not affect 
the relationship between growth faltering (as an exposure) and malaria (as an outcome) as long 
as malaria is measured after growth faltering (see Figure 3). However, anemia that is not caused 
by malaria may act as a confounder and we accounted for this potential confounding by 




Figure 3: Directed acyclic graph for the relationship between 
growth faltering, malaria, and malaria induced anemia. 
 
 
Figure 4: Directed acyclic graph showing the 
relationship between non-malarial anemia, 
malnutrition and malaria 
 
WHO defines anemia in children under 5 as a hemoglobin (Hb) concentration of <110 
g/l.103 They also define severe malarial anemia as Hb concentration <50 g/l in the presence of 
any density parasitemia.104 Previous research has shown that after an episode of malaria, iron 
absorption returns to near normal levels two weeks after successful anti-malarial therapy.105 We 
defined non-malarial anemia in this study as any anemia (<110 g/l hemoglobin) occurring 
without a concurrent parasite density (density = 0), and not within one month of clinical 
malaria infection. Non-malarial anemia was a dichotomous variable assessed in the month prior 
to the outcome. Any non-malarial anemia in the month prior to the outcome was coded as 1, 
otherwise 0. 
Time-fixed covariates that were measured at baseline included mother’s education, SES, 
village residence, maternal peripheral parasitemia and sickle cell genotype. 64% of mothers 
reported attending school for at least 7 years.97 Mother’s education was a dichotomous variable 
indicating less than 7 years of schooling or 7 years or more. SES was a dichotomous variable 
based on three indicators: ownership of more than one building within a compound, ownership 
of a bicycle and ownership of a pressure lamp as defined by Bloland et al, based on perceptions 
of residents in the study area at the time of data collection.97 Neighboring villages were grouped 
into four sectors, and sectors were coded as indicator variables. Maternal peripheral parasitemia 
density was a dichotomous variable, indicating presence or absence of peripheral blood 
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parasitemia at delivery. Sickle cell genotype was a three level indicator variable indicating the 
child’s genotype for sickle cell (HbAA – negative, HbAS – sickle cell trait, or HbSS – sickle cell 
disease).  
 
Statistical Analyses – Aim 1 
General Approach 
A polytomous logistic GEE model with an independent working correlation was used to 
model the effect of Z-score category on malaria outcomes.106,107 A different model was used for 
each type of nutritional index (HAZ, WAZ and WHZ) and outcome (prevalence and incidence). 
Interactions between the exposure and non-malarial anemia, and the exposure and age were 
also explored. Results from interaction models were compared to the single effect models. 
Within subject correlation was accounted for in the GEE model.108 
A polytomous logistic GEE model for the effect of Z-score category (A) on odds of 




� =  𝛼𝛼0𝑔𝑔 + 𝛼𝛼1𝑔𝑔𝑓𝑓(𝑡𝑡) + 𝛼𝛼2𝑔𝑔𝐴𝐴(𝑡𝑡) + 𝛼𝛼3𝑔𝑔𝐿𝐿(𝑡𝑡 − 1)       (1) 
 
where f(t) is a potentially non-linear function of time, A(t) represents Z-score category 
exposure, a2 is a vector of coefficients corresponding to each Z-score indicator variable, α3 is a 
vector of coefficients that correspond to the confounding variables, and g indexes across levels 
of the outcome.  
The polytomous logistic GEE models provided the following estimates: odds of incident 
clinical malaria vs no parasitemia, incident asymptomatic parasitemia vs. no parasitemia, 
prevalent clinical malaria vs. no parasitemia, and prevalent asymptomatic parasitemia vs. no 
parasitemia. The odds were then output as a ratio measure comparing odds among children 
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with severe, moderate, mild, or overweight – stunting, underweight or wasting – to those with 
no stunting, underweight or wasting.  
GEE models require the specification of a correlation structure that describes how each 
outcome at a given time is related to the other measurements for that same person at other 
timepoints. In this study an independent working correlation structure was used because this is 
the only correlation structure the SAS currently supports for multinomial models.  
A proportional odds model was also considered. The proportional odds model would 
have made use of the ordinal structure of the outcome categories. The proportional odds model 
assumes the odds ratio is constant, whether comparing children with clinical malaria to those 
without or children with any parasitemia to those with no parasites.  The proportional odds 
assumption was tested with a score test that compares ordinal vs. polytomous models.109 In this 
study the proportional odds assumption was found not to hold, and therefore a multinomial 
model was used. 
Requirements for the robust variance estimator in the GEE model include: a large 
number of subjects and little or no missing data (or data must be missing completely at random 
(MCAR)). While the number of subjects in this study was sufficient to satisfy the robustness 
property, there was a large amount of missing data, which was not necessarily MCAR. Missing 
data were handled through a combination of inverse probability weighting and multiple 
imputation, described below. 
Given the time varying nature of the exposures and the outcomes, time varying 
confounding affected by prior exposure was a concern. Figure 2 depicts the relationship between 
time varying Z-score (the exposure) and malaria. The red arrow from malaria at time t1 to Z-
score at time t2 is problematic because it creates a backdoor path when estimating the effect of 
Z-score at time t2 on malaria at time t3. To avoid potential confounding by previous malaria 
infection, which may be influenced by prior exposure, we estimated the parameters of a 
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marginal structural model (MSM), which used inverse probability of exposure weights to 
remove the association between malaria at time t1 and Z-score at time t2 (the red arrow).  
A polytomous logistic repeated measures MSM for the effect of categorical Z-score (A) on 
odds of clinical malaria or asymptomatic parasitemia infection (Y) is:  
 
𝐸𝐸[𝑌𝑌𝑎𝑎(𝑡𝑡 + 1)] = 𝛿𝛿0 + 𝛿𝛿1𝑓𝑓(𝑡𝑡) + 𝛿𝛿2𝑎𝑎(𝑡𝑡)         (2) 
 
where Ya is the potential outcome under an intervention to set A to a specific categorical Z-score 
level a, f(t) is a potentially non-linear function of time, and A(t) is categorical Z-score exposure. 
Model 2 provided the following estimates: odds ratios comparing odds of malaria incidence or 
prevalence among children with severe, moderate, mild, or overweight – stunting, underweight 
or wasting – to those with no stunting, underweight or wasting, weighted to remove 
confounding by baseline and time varying covariates affected by prior exposure (𝛿𝛿2).  
Missing Data 
There was a large amount of non-monotone missing height and weight data in the ABCP 
study. Missing height and weight data occurred due to dropout, missed visits, and within 
completed visits (nonresponse).  Missing data can be classified based on the type of missingness. 
Missing completely at random (MCAR) means that the observed data are a simple random 
sample of the complete data, and that we expect the missing and observed values to have similar 
distributions. Missing at random (MAR) means that missingness can be predicted by other 
observed variables in the dataset (and notably that missingness does NOT depend on the 
missing variable itself). Missing not at random (MNAR) means that being missing is dependent 
on unobserved variables.110 MCAR was assessed for nonresponse missing height and weight data 
by conducting bivariate analyses to determine if measured variables were associated with 
missingness. MAR cannot be tested in the data, yet plausible reasons for height and weight 
nonresponse might be: 1. Random: height and weight were only measured every other visit, it is 
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possible the data collection team could have been unsure whether measurements were required 
and chosen not to take them), 2. Behavior of the child: if a child would not stand or lie still to be 
measured – in this case sick children would be more likely to be measured than well children, 
and this was assessed in the data. Missing height and weight data were found to be associated 
with non-malarial infection, residence sector, season, age, and maternal peripheral parasitemia. 
Data may also be missing due to dropout or missed visits. Various reasons for dropout 
might include illness, death, or relocation away from study site. Missed visits may have occurred 
due to illness, or being away during the visit time. Missing data due to missed visits and dropout 
were assumed not to be MCAR, and were accounted for through inverse probability weighting. 
To account for both types of missing data, inverse probability weighting methods were 
combined with multiple imputation methods.111 Multiple imputation methods were used to 
impute Z-scores and other missing data for individuals who were seen at a specific visit, but for 
whom certain variables were not recorded.112 Inverse probability weights were then calculated 
and applied to the models to weight the dataset to account for individuals with completely 
missed visits, and those who dropped out. This down-weighted the individuals who were seen at 
these visits to make the dataset representative of the entire study population, both those who 
were seen and those who were not. In total, three different types of inverse probability weights 
were applied to the models: 
1) Inverse probability of observation weights: these weights accounted for children who 
missed complete visits 
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3) Inverse probability of exposure weights: these weights were applied to remove the 
association between previous malaria infection and current Z-score, to prevent time 
varying confounding affected by prior exposure. For continuous Z-score exposures 
inverse probability of exposure weights were calculated using quantile binning113 to 
calculate conditional probabilities of exposure. 
𝑆𝑆𝑆𝑆𝑖𝑖
𝐸𝐸1(𝑡𝑡) =  �
𝑃𝑃𝑃𝑃[𝐴𝐴(𝑘𝑘) = 𝛼𝛼| 𝑘𝑘]







The final marginal structural models (equation 2) were weighted by the product of each of the 






In equations 3, 4 and 5, 𝐴𝐴(𝑘𝑘) is the exposure at time k, 𝑌𝑌�(𝑘𝑘) is history of the outcome up 
to time k,  𝐿𝐿�(𝑘𝑘) is a vector of potential confounders at time k. 𝑉𝑉 is a subset of 𝐿𝐿�(𝑘𝑘) , denoting a 
vector of time-independent baseline covariates, 𝐶𝐶(𝑘𝑘) is an indicator of censoring, and 𝑂𝑂(𝑘𝑘) is an 
indicator of being observed at time k. 
The assumptions and conditions required for the MSM include exchangeability, 
consistency, positivity and correct model specification. Exchangeability implies no unmeasured 
confounding or sources of selection bias. It is assumed that appropriately accounting for all 
confounders is sufficient to create exchangeability between individuals who were exposed to 
various levels of malaria and those who were not.114 Unfortunately, this study is missing data on 
an important potential confounder, HIV/AIDS status. Therefore the weighted linear regression 
models did not satisfy the criteria for the exchangeability assumption.  We conducted the 
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analysis without completely satisfying the exchangeability assumption, and conducted a 
separate bias analysis that estimated the magnitude of potential confounding by HIV/AIDS 
status. This analysis is described below in the Bias Analysis section. 
Two additional conditions for the use of MSMs are consistency and positivity. 
Consistency means that an individual’s counterfactual outcome under an observed exposure is 
the same as the individual’s observed outcome for that same exposure, or put another way, that 
assigning an individual’s exposure has the same outcome as an observed exposure.114 
Consistency is untestable in the data but we do our best to ensure this condition by having well 
defined exposures.   
Positivity specifies that there is a non-zero probability for each exposure level within 
each observed combination of confounders.114  We did not expect there to be any structural 
violations of positivity, whereby an individual cannot possibly be exposed or unexposed at 
certain levels of a confounder. The likelihood of random non-positivity increases with the 
number of confounders and with highly stratified data. For this reason most confounders 
considered for inclusion in the weight models were either dichotomous or categorical variables. 
Higher order polynomials were used to better model the relationship between continuous 
variables such as age (time) and the exposure to facilitate correct model specification. 
Confounders were identified from a DAG analysis, and strength of confounding was determined 
from published literature. Stabilized weights were used to minimize nonpositivity.114 Positivity 
was assessed in the data by examining the weight distribution 
Bias Analyses – Aim 1 
Selection Bias 
The study may be subject to selection bias, as only 50% of the cohort completed visits 
past 12 months of age. As described above, selection bias due to dropout was corrected through 
inverse probability weighting.  
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Missing Confounder Data 
A limitation to this study was the lack of data on HIV status, which may be a confounder 
of the relationship between both growth faltering and malaria. HIV has been shown to increase 
prevalence of clinical malaria in children, but it has not been shown to affect parasite density in 
children.115 HIV may be a confounder of the effect of growth faltering on clinical malaria and 
asymptomatic malaria. It is important to note that HIV does not impair response to treatment, 
even in children with low CD4 counts, and the risk of malaria recrudescence among HIV positive 
children is not increased.115 Additionally, a recent study in Uganda found that the relationship 
between stunting and malaria was consistent across HIV infected and uninfected children.69 
To estimate the amount of bias introduced by unmeasured confounding from HIV 
infection methods presented by Schneeweis, et al were used.116 This method utilizes three 
parameters: 
1. The association between the confounder and the outcome among those who were 
unexposed (RRCD). 
2. The association between the exposure and the confounder (OREC). 
3. The prevalence of the confounder in the source population (Pr(C)). 
 
There have been no studies that have investigated the relationship between HIV and 
malaria (RRCD), while adjusting for nutritional status. The few studies that have been conducted 
indicated either an increased risk of clinical malaria among HIV infected individuals (IRR = 1.7 
among children under 5 in Uganda,117 and RR = 1.42 among children with a median age of 6-7 in 
Congo118), a decreased risk119 or no difference.120 The association between growth faltering and 
HIV (OREC) also has a limited number of studies. The results of these are presented in Table 4, 
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The prevalence of HIV in the source population (Pr(C)) can be estimated as follows: The 
prevalence of HIV among pregnant women during the time of the study was 30% or less.126 Risk 
of mother to child transmission without treatment during pregnancy, labor and delivery is 25%. 
Breastfeeding increases this risk by 12%. Therefore the risk of infection among children born to 
HIV positive mothers not on treatment at this time can be estimated as 37%.127 If we multiply 
the prevalence of HIV among pregnant women by the probability of passing the infection along 
to their child, the upper bound of the expected proportion of infected children in the study is 
11%. A study conducted in Kisumu from 1996-2000 showed a cumulative prevalence of HIV in 
the first year of life of 22.5% among children born to HIV infected mothers who were not treated 
during pregnancy, childbirth and breastfeeding.128 If we multiply this prevalence by the expected 
prevalence of HIV infected mothers (30%) we get an estimated 6.75% of infants who would be 
HIV infected. Therefore our estimate of 11% HIV prevalence in this population is conservative; 
the true prevalence was most likely in the range of 5-10%. 
Table 7 estimates the percent bias that may have been introduced into the estimates for 
the effect of malnutrition on malaria through confounding by HIV status of the child. The 
apparent relative risk between exposure and disease is the relative risk that would be seen if no 
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confounders were controlled for, given the calculated bias contributed by a specific confounder 
(here, HIV) based on the parameters discussed above, and shown in the table (RRCD, OREC, and 
Pr(C)), assuming the true relative risk is 1. The percent bias is the percentage that the true 
relative risk is altered by the confounder. Based on the assumptions presented here, the effect 
estimates for this study were biased anywhere from 2-8% for stunting, 1-13% for underweight, 
and 0-14% for wasting. 
 
Table 7: Assessment of confounding bias in estimates of the effect of malnutrition on incident 
malaria, Aim 1 
Nutrition Metric Type of Estimate OREC
a Pr(E)b Pr(C)c RRCD
d Apparent RRED
e % Biasf 
Stunting Lower Bound 2 0.39 0.05 1.7 1.02 2% 
Stunting Upper Bound 3.5 0.39 0.11 1.7 1.08 8% 
Underweight Lower Bound 1.25 0.12 0.05 1.7 1.01 1% 
Underweight Upper Bound 4.15 0.12 0.11 1.7 1.13 13% 
Wasting Lower Bound 1 0.04 0.05 1.7 1.00 0% 
Wasting Upper Bound 4 0.04 0.11 1.7 1.14 14% 
a Odds ratio between malnutrition and HIV 
b Marginal probability of exposure – prevalence of the corresponding type of malnutrition in the source population, calculated 
from the dataset. 
c Marginal probability of confounder (HIV) 
d Risk ratio between confounder and disease 
e Apparent relative risk between exposure (malnutrition) and disease (malaria) if the potential confounders were not 
controlled, under the assumption that the true relative risk is 1. 
f Bias = [(apparent RRED – true RRED)/true RRED]*100 
 
Power – Aim 1 
Statistical power was assessed using PROC POWER in SAS v. 9.2 (SAS Institute, Cary, 
NC). A two tailed test was used with a type I error probability of 5%.  
Based on Bloland, et al’s original analysis of the data, the proportion of records with 
clinical malaria was estimated to be 19%, based on a weighted, age stratified analysis. Power to 
detect an odds ratio (OR) ranging from 1.1 to 1.5 was estimated, based on varying effective 
sample sizes. Because the data include repeated measures on individuals over time, the total 
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effective sample size was adjusted down to account for clustering.129,130 The effective sample size 
(ESS) was calculated as: 
 
𝐸𝐸𝑆𝑆𝑆𝑆 =  𝑚𝑚∗𝑘𝑘
𝐷𝐷𝐸𝐸
            (7) 
 
In equation 7, m is the number of observations per cluster (observations per child), k is 
the number of clusters (children), and DE is the design effect. The design effect was calculated 
as: 
 
𝐷𝐷𝐸𝐸 = 1 + ((𝑚𝑚− 1) ∗ 𝜌𝜌)           (8) 
 
In equation 8, ρ is the intracluster correlation coefficient.130 This can vary from 0 to 1, 
with values closer to 1 indicating a higher degree of correlation between responses within a 
cluster. Because the clusters in this study are individual children, we assume a high degree of 
correlation between data points for the same child. Therefore ρ is assumed to range from 0.7 to 
0.9. Based on equation 4, with m=24,365 (person months of follow up), DE ranges from 8.7 to 
10.9. The corresponding ESS ranges from 2235 to 2800. As shown in Figure 6, the study should 
have 80% power to detect an odds ratio of ~1.3 based on a varying ESS. Previous studies have 
shown relative risks for the effect of underweight on clinical malaria ranging from 1.169 to 1.3.74 
The only meta-analysis showed a pooled risk ratio for the effect of underweight on malaria of 
1.31.131  Two additional studies on underweight and malaria found odds ratios of 1.3172 and 
1.67.132 Previous studies on the effect of stunting on clinical malaria have found effect estimates 
ranging from an odds ratio of 1.272 to risk ratios of 1.4.68,69 Based on previous research, the 
expected risk ratio is in the range from 1.2 to 1.4. We will be estimating odds ratios, which 













Aim 1 also estimated the odds ratio for asymptomatic parasitemia vs. none. 
Approximately 34% of blood smears were negative for parasites over the first two years of the 
study, according to Bloland et al.134 Based on the design effect and effective sample size 
calculated above, this gives this analysis 80% power to detect an odds ratio of ~1.25 or greater 







































Figure 6: Power to detect different odds ratios across varying effective sample 




Figure 7: Power to detect different odds ratios across varying effective sample 
sizes, comparing children with parasites to those without 
 
 
Aim 2 Analysis 
 In Aim 2 we investigated the effect of cumulative malaria on children’s growth from birth 
through 30 months. The sub aims were:  
Sub Aim A: Estimate the cumulative effect of malaria and any parasitemia on height-for-
age Z-score in children ages 0-30 months. 
Sub Aim B: Estimate the cumulative effect of malaria and any parasitemia on weight-for- 
height Z-score in children ages 0-30 months. 
 
Causal Diagram 
A basic directed acyclic graph (DAG) showing the time varying nature of the exposures, 
outcome, and one covariate, C, is shown in Figure 8 below. Covariates that were adjusted for in 
the model were chosen from a DAG analysis. A full DAG showing all potential confounders for 
Aim 2 is shown in Appendix B. The chosen covariates block all non-causal paths between the 






















Figure 8: Directed Acyclic Graph showing the relationship between malaria and attained growth 
(Z-score). 
C indicates infection, which is a measured time-varying confounder. Red lines indicate associations 




Exposure variable – cumulative incident clinical malaria 
Clinical malaria was defined the same as in Aim 1 – presence of any parasitemia with 
fever. Each episode of clinical malaria was considered an incident infection if the previous 
month showed no parasitemia. Incident malaria was summed from birth through the current 
record to create a cumulative incident clinical malaria variable. This was a discrete, ordinal 
variable. Based on the bivariate relationship between the exposure and the outcome, this 
variable was topcoded at four episodes of cumulative incident clinical malaria. Therefore the 
variable indicated 0, 1, 2, 3, or 4 or more episodes of clinical malaria. 
Exposure variable – cumulative prevalent clinical malaria 
For this exposure each month with clinical malaria was summed from birth through the 
current record to create a cumulative prevalent clinical malaria variable. This was a discrete, 
ordinal variable. This exposure variable was topcoded at six months – indicating 0,1,2,3,4,5, or 6 




 Exposure variable – cumulative asymptomatic parasitemia 
Aim 2 also investigated the cumulative effect of parasitemia on growth. Parasitemia was 
defined as the presence of any malaria parasites, with or without fever. Each month in which 
any parasitemia was present was summed from birth through the current record to create a 
cumulative parasitemia variable. This was also a discrete ordinal variable, and was topcoded at 
ten months. 
Outcome variable – nutritional status 
In Aim 2, we used all three nutritional indexes, height-for-age, weight-for-age, and 
weight-for- height, as outcome variables. Height-for-age and weight-for-height Z-scores were 
investigated in the primary analysis, and weight-for-age Z-score was investigated in a secondary 
analysis. Z-scores calculated in Aim 1 were used as continuous outcome variables. Please see 
Aim 1 for more information on data cleaning, and calculation of Z-scores. 
Covariates 
Covariates that were included as potential confounders included: season, mother’s 
education, socioeconomic status (SES), infant age, residence, non-malarial infection, maternal 
peripheral parasitemia at delivery, sickle cell genotype, and non-malarial anemia. Potential 
confounders were identified from a DAG analysis.  
Time varying covariates included season, infant age (time), non-malarial anemia, and 
non-malarial infection. Season, infant age and non-malarial infection were coded as in Aim 1: 
Season was categorized into rainy, dry and transition periods and coded as indicator variables. 
Infant age was again included as time, calculated as months from birth (the origin). This 
ensured infants of the same age were being compared. A non-malarial illness variable was 
derived and defined as a dichotomous variable indicating presence of any of the following in the 
absence of malaria parasitemia: inability to drink, chills, diarrhea, vomiting, difficulty breathing, 
or fever. Non-malarial anemia was coded similar to Aim 1. It was a dichotomous variable 
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indicating any anemia (<110 g/l hemoglobin) occurring without a concurrent parasite density 
(density = 0), and not within one month of clinical malaria. Non-malarial illness and non-
malarial anemia were measured in the month prior to the exposure, to ensure they occurred 
temporally prior to the exposure, and could therefore be used to predict exposure status when 
inverse probability of treatment weights were calculated. Season and age (time) were calculated 
concurrent to the exposure, as these variables cannot be influenced by the exposure. 
The same time-fixed covariates considered in Aim 1 were used in Aim 2: mother’s 




The standard statistical approach to estimate the effect of a time varying exposure, such 
as malaria, on the mean of a repeatedly measured outcome is to model the mean of the outcome 
at each time as a function of past exposure. However, this approach may be biased in the 
presence of a time varying confounder that is a) associated with subsequent exposure b) 
associated with the outcome and c) affected by prior exposure.135 
Figure 9 below demonstrates the relationship between malaria as a time varying 
exposure, and Z-score as a repeated outcome. The total effects of malaria at times 0 and 2 on Z-
score are shown with blue arrows. Assessing the causal effect of malaria at time 2 on Z-score at 
time 3 is problematic because the red arrow opens up a backdoor confounding path from Z-
score at time t1 to Z-score at time t3. If we control for Z-score at time t1 as a confounder by 
including it as a covariate in the model, we then block a causal path from malaria at t0 to Z-




Figure 9: Directed acyclic graph showing the relationship between malaria as a time varying 
exposure and growth as a repeated outcome. 
 
In the analysis for Aim 2, prior anthropometric Z-score is a time-varying confounder 
affected by prior exposure. It predicts future anthropometric Z-score, and may affect future 
malaria susceptibility, but may also be affected by past malaria history. To account for time-
varying confounding by prior anthropometric Z-score, inverse probability of exposure weights 
(IPEWs) were applied to the standard GEE model. The weighted GEE model estimated the 
parameters of a marginal structural model, providing an estimate of the mean change in 
anthropometric Z-score resulting from a one-unit change in cumulative clinical malaria 
incidence, or a one unit change in cumulative months of asymptomatic parasitemia, accounting 
for all time-varying confounders including prior anthropometric Z-score. The use of the 
weighted GEE model prevented the potential for selection bias and removed indirect effects of 
interest that can occur with the standard regression adjusted GEE model.  Additionally, the 
exposure was accumulated up to one month prior to the outcome measurement, ensuring the 
outcome occurred temporally after the exposure. The MSM was the primary analysis, however a 
standard GEE model was also explored, to determine the extent to which (if any) the results of 
the MSM were different from the GEE, providing an indication of the severity of time-varying 





A linear GEE model for the effect of cumulative malaria (A) on anthropometric Z-score 
(Y), adjusted for confounders (L) is: 
𝐿𝐿𝐿𝐿(𝐸𝐸[𝑌𝑌(𝑡𝑡 + 1)|𝐴𝐴(𝑡𝑡),𝐿𝐿(𝑡𝑡 − 1)]) =  𝛾𝛾0 + 𝛾𝛾1𝑓𝑓(𝑡𝑡) + 𝛾𝛾2𝑓𝑓(𝐴𝐴(𝑡𝑡)) + 𝛾𝛾3𝐿𝐿(𝑡𝑡 − 1) (9) 
 
where f(t) is a potentially non-linear function of time, f(A(t)) is a linear function of cumulative 
malaria exposure, and 𝛾𝛾 3 is a vector of coefficients that correspond to the confounding variables. 
Considering f(A(t)) was a linear function, the linear GEE models provided the following 
estimates: The mean change in Z-score resulting from one month additional exposure to malaria 
(or one month additional exposure to any parasitemia), adjusted for all confounders in the 
month prior to final exposure measurement (𝛼𝛼3). 
The linear repeated measures MSM for the effect of cumulative clinical malaria or 
parasitemia (A) on anthropometric Z-score (Y) is:  
𝐸𝐸[𝑌𝑌𝑎𝑎(𝑡𝑡 + 1)] = 𝛿𝛿0 + 𝛿𝛿1𝑓𝑓(𝑡𝑡) + 𝛿𝛿2𝑓𝑓(𝑎𝑎(𝑡𝑡)) (10) 
 
where Ya is the potential outcome under an intervention to set A to a specific cumulative malaria 
level a, f(t) is a potentially non-linear function of time, and f(A(t)) is a linear function of 
cumulative malaria exposure. Assuming f(A(t)) is a linear function, Model 10 provides the 
following estimate: the mean change in Z-score resulting from one month additional exposure to 
malaria (or one month additional exposure to any parasitemia), weighted to remove 
confounding by baseline and time varying covariates affected by prior exposure (𝛿𝛿2).  
With an ordinal exposure such as cumulative malaria incidence, we again calculated 
inverse probability of exposure weights using quantile binning113 to calculate conditional 
probabilities of exposure. The stabilized weights were: 
𝑆𝑆𝑆𝑆𝑖𝑖
𝑂𝑂1(𝑡𝑡) =  �
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Model 10 was weighted by the final stabilized weight, calculated for each individual i at each 
time point k:      𝑆𝑆𝑆𝑆𝑖𝑖(𝑡𝑡) =  𝑆𝑆𝑆𝑆𝑖𝑖𝑂𝑂 ∗ 𝑆𝑆𝑆𝑆𝑖𝑖𝐶𝐶 ∗ 𝑆𝑆𝑆𝑆𝑖𝑖𝐸𝐸                                                (14)                             
 
The same assumptions and conditions discussed for Aim 1 also apply for Aim 2: exchangeability, 
consistency, positivity and correct model specification.  
 
Bias Analysis 
Missing Data and Selection Bias 
Missing outcome data for Aim 2 occurred due to dropout, missed visits, and within 
completed visits (nonresponse).  Data that are stratified MCAR can be analyzed with inverse 
probability weights. In this scenario, complete cases are weighted by the inverse of their 
probability of being a complete case. Weights were calculated from a missingness model that 
specified the probability of being observed based on variables that predicted missingness and 
variables that predicted the exposure and the outcome.136 Inverse probability weights cannot 
extend the working assumption to MAR with a non-monotone missing data pattern.137 Therefore 
a combination of multiple imputation and inverse probability weighting was used, similar to 
Aim 1.  
Missing Confounder Data 
For Aim 2 we also explored the effect of potential confounding bias due to unmeasured 
HIV status. We used the following parameters to calculate the percent bias that is expected from 
confounding, based on work by Schneeweis et al:116  
1) The association between the confounder (HIV) and the outcome (Z-score) among 
those who were unexposed (RRCD). We do not have information on the association 
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between HIV and malnutrition specifically among those without malaria, but based 
on Table 4 and Table 6 from Aim 1, we can estimate the RR for the effect of HIV on 
stunting to be between 1.34 and 2.80. For wasting, the only significant RR estimate is 
3.09.  
2) The association between the exposure (malaria) and the confounder (HIV) (OREC).  
The two studies that show an increased risk of malaria among children with HIV had 
an incidence odds ratio of 1.48118 and an incidence rate ratio of 1.7.117 We assumed the 
OREC has a range from 1.5-2, because the odds ratio can often overestimate the RR, 
especially when the outcome is common. 
3) The prevalence of the confounder in the source population (Pr(C)). This was 
calculated for the sensitivity analysis in Aim 1, and we assumed the prevalence of 
HIV in this population of children in Kenya during the early nineties was in the range 
from 0.05-0.11. 
 
Table 8 estimates the percent bias that we estimated was introduced into the estimates 
for the effect of cumulative malaria on Z-score through confounding by HIV status of the child. 
Based on the assumptions presented here, the effect estimates for this study may be biased 









Table 8: Assessment of confounding bias in estimates of the effect of cumulative malaria on growth, 
Aim 2 
Nutrition Metric Type of Estimate OREC
a Pr(E)b Pr(C)c RRCD
d Apparent RRED
e % Biasf 
Stunting Lower Bound 1.5 0.66 0.05 1.3 1.01 1% 
Stunting Upper Bound 2 0.66 0.11 2.8 1.10 10% 
Wasting Lower Bound 1.5 0.66 0.05 3.09 1.03 3% 
Wasting Upper Bound 2 0.66 0.11 3.09 1.11 11% 
a Odds ratio between malaria and HIV 
b Marginal probability of exposure – prevalence of malaria in the source population, calculated from the dataset. 
c Marginal probability of confounder (HIV) 
d Risk ratio between confounder and disease 
e Apparent relative risk between exposure (malaria) and disease (low Z-score) if the potential confounders were 
not controlled, under the assumption that the true relative risk is 1. 
f Bias = [(apparent RRED – true RRED)/true RRED]*100 
 
Power 
There are no formal methods for assessing power for MSMs. The required sample size 
for a GEE linear model needed to obtain power of 80% for varying effect sizes was calculated. 
This number was then inflated by 20% to account for the lower power and precision of the 
MSM. Statistical power was assessed using PROC POWER in SAS v. 9.2 (SAS Institute, Cary, 
NC). A two tailed test was used with a type I error probability of 5%.  
The effective sample size for Aim 2 is the same as in Aim 1: ranging from 2235 to 2800. 
(See Figure 5). The inflated sample size needed to detect a Pearson correlation from -0.05 to -
0.5 between Z-score and cumulative malaria with a power of 80% is shown in Figure 10. The 








Figure 10: Power to detect different levels of correlation between 






































CHAPTER 4: AIM 1 - THE ASSOCIATION OF MALNUTRITION WITH 
SUBSEQUENT CLINICAL MALARIA AND ASYMPTOMATIC PARASITEMIA 
AMONG CHILDREN UNDER THREE IN KENYA 
 
Introduction 
Malaria and malnutrition remain primary causes of morbidity and mortality among 
children under five. Recent estimates indicate over 250,000 children died from malaria in 
2017.2 In Africa malaria remains a leading cause of childhood mortality.1 In 2017, 58.7 million 
African children (30%) under the age of five were  stunted (low height-for-age), and 13.8 million 
(7%) were wasted (low weight-for-height).20 East Africa and Kenya have particularly high 
burdens of malnutrition. Over one third (36%) of all children in East Africa are stunted.20 In 
Kenya alone, almost 2 million children (26%) under five were stunted in 2014.138  
Malnutrition, a syndrome of inadequate intake and absorption of protein, energy and 
micronutrients combined with frequent infections that results in poor growth,22 affects a large 
proportion of children in malaria endemic regions. Malnutrition may alter susceptibility to 
malaria infection or increase severity of the disease by weakening the immune system and 
preventing an adequate immune response against malaria. Malnutrition can impair the adaptive 
and innate immune responses, both of which are involved in the immune response to malaria.40 
The innate immune system limits parasite density while the adaptive immune response works to 
remove the parasite.43 Malnutrition may impair children’s ability to clear an infection, resulting 
in higher population prevalence or increased severity of disease. Malnutrition may also increase 
children’s susceptibility to infection, resulting in higher population incidence. Different types of 
malnutrition, such as stunting or wasting, may also have different effects on children’s 
susceptibility and response to malaria. 
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Results of previous studies on the relationship between malnutrition and malaria have 
been inconsistent. Most previous studies investigated the association of malnutrition, measured 
as anthropometric z-score, with clinical malaria incidence. All but one study72 defined clinical 
malaria as fever with diagnostically confirmed malaria, however varying parasitemia thresholds 
were used depending on the local epidemiology of malaria. Two longitudinal studies found a 
significant association between malnutrition and increased malaria incidence,68,69 while two 
others found a significant association between wasting70 or stunting71 and decreased malaria 
incidence. Most studies have found no statistically significant association between 
undernutrition and malaria.70,72–76 Inconsistency in the results of previous studies may be due to 
differences in study population, differences in study design aspects such as measures of 
malnutrition, malaria or control for confounding, and other factors involved in the host-parasite 
relationship.139 In addition, half of the previous studies were conducted in the era prior to 
widespread use of effective malaria interventions such as distribution of insecticide treated nets 
(ITNs), indoor residual spraying (IRS) and treatment with artemisinin-based combination 
therapy (ACT).68,71–74 The scale-up of both malaria and nutrition interventions over the past 
twenty years may have changed the relationship between malnutrition and malaria. 
A proportion of malaria infections, especially in highly endemic areas, may be  
asymptomatic.17,18 Many asymptomatic infections go untreated, yet they can adversely affect 
children’s health, contributing to low grade inflammation, lower hemoglobin and platelet 
counts,17 chronic anemia, cognitive impairment and reduced school performance.140 
Asymptomatic infections can also contribute to ongoing malaria transmission.18,140  Only five 
previous studies investigated the association of malnutrition with asymptomatic parasitemia, 
also with inconsistent results.47,59,71,77,141  
This study utilized a rich dataset from an era pre-dating mass scale-up of malaria 
interventions to investigate whether incident or prevalent asymptomatic parasitemia or clinical 
malaria was associated with prior malnutrition among children under three years of age in 
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western Kenya. The recent slowing of progress in malaria control,2 and continued increase in the 
absolute number of stunted children in Africa20, makes elucidating the interactions between 
malaria and malnutrition a high priority. As the public health community strives to further 
reduce the burdens of both malnutrition and malaria, effective targeting of limited services and 
supplies will be crucial. Using data that were collected prior to the mass scale-up of malaria 
interventions allows for an analysis with greater power to detect associations, given the high 
prevalence of both malaria and malnutrition during this time period. The results may be used to 
prioritize interventions and research priorities as the global response for both malnutrition and 
malaria becomes more focused and strategic in an effort to meet long term goals.142,143   
 
Methods 
Study Site and Sample 
Data for this study come from the Asembo Bay Cohort Project conducted in 15 villages in 
the Asembo Bay area of Siaya District in Nyanza Province, western Kenya between 1992 and 
1996. The study was designed to assess the epidemiology, entomology, immunology, host 
factors, molecular biology, antigenic variation, and population genetics of P. falciparum in a 
large cohort of women and children in an area with intense malaria transmission. Malaria was 
holoendemic in the study site, with an estimated entomologic inoculation rate of 0.75 infective 
bites per person per day.96 This area has two rainy seasons from March to May and October to 
December, and two dry seasons from January to February and June to September. During the 
study period, chloroquine was the only malaria intervention available at health facilities in the 
study area.144 
Beginning in June 1992, all pregnant women in participating villages were identified 
during a monthly census by trained community health workers or birth attendants residing in 
the same village. Women who provided informed consent were enrolled in the study and visited 
every month at home by village monitors who administered standard questionnaires and 
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obtained axillary temperatures, thick and thin blood smears and capillary blood samples 
preceding delivery. Mother-infant pairs were visited within two weeks of birth and then every 
two weeks thereafter. At each visit, questionnaires were administered and the children’s health 
was reported by the mother or an adult sibling or guardian. Axillary temperatures were obtained 
using a digital thermometer. Capillary blood, thick and thin blood films, and anthropometrics 
were collected every four weeks, at every other visit. Height and weight were measured in 
centimeters and kilograms (respectively) to the nearest 10th. Children who were old enough to 
stand were measured standing, all others were measured recumbent. Any participant with 
documented fever and malaria parasitemia received a treatment dose of 
sulfadoxine/pyrimethamine.  More severe illnesses were referred to local health facilities. 
Mother-infant pairs were followed until loss to follow-up, death, end of the study, or the infant’s 
fifth birthday.97 
All blood films were stained with Giemsa and parasite densities were quantified by 
counting the number of asexual parasites per 300 leukocytes. Parasite density was calculated 
assuming a leukocyte count of 8,000/mm.134 Hemoglobin concentration (g/dL) was measured 
using the HemoCue system (HemoCue, Anglholm, Sweden).98 Hemoglobin genotyping was done 
retrospectively using a polymerase chain reaction method.99 Additional details regarding 




Z-scores comparing a child’s length/height-for-age (HAZ), weight-for-age (WAZ) and 
weight-for-length/height (WHZ) to a reference population were calculated using the World 
Health Organization’s (WHO) Multi Centre Growth Reference Study.100 Linear growth was 
considered as length for children under two, and height for children two and older. For 
simplicity we will refer to height as the linear growth measurement, regardless of the age of the 
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child. Three different four-level ordinal categorical exposure variables were created for each z-
score measure: 1) HAZ: severe stunting (≤ -3), moderate stunting (> -3 and ≤ -2), mild stunting 
(> -2 and <0), and not stunted (≥0); 2) WAZ: moderate underweight (≤ -2), mild underweight 
(> -2 and < 0), not underweight ( ≥ 0 and < 1), and overweight (≥ 1); 3) WHZ: moderate wasting 
(≤ -2), mild wasting (> -2 and < 0), not wasted (≥ 0 and < 2), and overweight (≥ 2).  If more 
than two height and weight measurements were made within a one month period, the z-scores 
for these measurements were averaged together before creating categorical variables.  
Z-scores  outside plausible bounds were flagged and changed to missing, according to the 
following guidelines defined by WHO100: Weight-for-age Z-score less than -6 or greater than 5; 
height-for-age Z-score less than -6 or greater than 6; weight-for-height Z-score less than -5 or 
greater than 5. Accordingly, 215 (0.5%) HAZ, 54 (0.1%) WAZ and 223 (0.5%) WHZ 
measurements were flagged and changed to missing. 
Beyond the WHO guidelines for plausible Z-score records, there is a lack of research on 
methods to further assess the accuracy of longitudinal anthropometric data. A method to 
visually assess plausibility of height measurements was defined based on previously described 
methods.101 Height for each child was graphed over time and flagged for visual inspection if it 
indicated a decrease from the previous measure of more than two cm (regardless of the length of 
time between the two consecutive measures). Flagged heights that appeared as a "divot," 
deviating from the height trend, were discarded if the following point returned to the original 
height trend. The previous height was discarded if it appeared as a “peak,” where it deviated 
above the height trend, and the following height returned to the original trend. The last height 
measurement on a child was not flagged for missing unless it was clear there was a loss of height 
from a consistent height trend in the previous measurements. If no immediate trend could be 
seen in the measurements before or after the flagged height, the flagged measurement remained 
in the data. In the original dataset, 1,057 (6%) height measurements were flagged and visually 




Both prevalent and incident malaria were investigated as outcomes. A repeated measure, 
three-level, ordinal categorical variable was created indicating: 1) no parasitemia; 2) 
asymptomatic parasitemia (presence of parasites without fever); and 3) clinical malaria 
(presence of parasites with fever - axillary temperature ≥ 37.5°C). For prevalent malaria the 
entire sample was included in the analysis and both asymptomatic and clinical malaria were 
defined as the presence of parasites with (clinical), or without (asymptomatic) fever in the 
month following the exposure, regardless of the child’s current malaria status. For incident 
malaria, the sample was restricted to visits with a negative blood film concurrent to the exposure 
measurement, limiting the population to children who could be at risk for an incident infection 
in the following month. Incident asymptomatic parasitemia and incident clinical malaria were 
then defined as the presence of parasites with (clinical) or without (asymptomatic) fever in the 
month following exposure, among children with a current negative blood film. Outcomes 
measured two and three months after the exposure were also considered. 
Covariates 
Covariates were identified from a directed acyclic graph145 informed by the literature. 
Time varying covariates included non-malarial anemia,32,146,147 season,134,148,149 age,134 and non-
malarial infection.57,78,150 Non-malarial anemia was defined as a dichotomous variable indicating 
any anemia (<110 g/l hemoglobin) occurring without a concurrent parasite density (density = 
0), and not within one month following a clinical malaria infection. This was assessed in the 
month prior to the outcome. This variable was included as a proxy for iron-deficiency anemia, 
which may be a confounder of the relationship between malnutrition and malaria. However, 
given the numerous causes of anemia in this population, the effectiveness of this variable as a 
proxy for iron deficiency anemia may be limited. Season was a three level-indicator variable 
denoting dry, rainy and transition months. Non-malarial infection was a dichotomous variable 
assessed in the month prior to the exposure indicating inability to drink, experience of chills, 
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diarrhea, vomiting, difficulty breathing, or fever, in the absence of malaria parasitemia. Time 
was included as age (months from birth) and modeled as a cubic term, based on the quasi 
Akaike information criterion (QIC) comparing multiple functional forms.151   
Time-fixed covariates included child sex,152 mother’s education,153,154 SES,155,156 residence 
sector,155,157–159 maternal peripheral parasitemia at delivery,160,161 and sickle cell genotype.162,163 
Mother’s education was a dichotomous variable indicating less than 7 years of schooling or 7 
years or more. SES was a dichotomous variable based on three indicators: ownership of more 
than one building within a compound, ownership of a bicycle and ownership of a pressure lamp, 
based on perceptions of residents in the study area at the time of data collection.97 Villages were 
grouped into four different sectors and coded as indicator variables. Maternal peripheral 
parasitemia density was a dichotomous variable indicating presence or absence of peripheral 
blood parasitemia at delivery. Sickle cell genotype was coded as indicator variables (HbAA – 
negative or HbAS – sickle cell trait, or HbSS – sickle cell disease).  
Auxiliary Variables 
Auxiliary variables that were used in the multiple imputation model included mother’s 
height, birth rank and gestational age. Mother’s height was a dichotomous variable indicating 
less than 158cm or 158cm or more. Birth rank was a dichotomous variable indicating the child’s 
rank at birth (singleton or twin). Gestational age was an ordinal variable indicating weeks of 
gestational age at birth. 
 
Statistical Analysis 
Multinomial generalized estimating equation (GEE) models with an independent 
working correlation structure were used to estimate the association between malnutrition and 
subsequent malaria while accounting for repeated observations on the same children over 
time.107 First, an unweighted model was used that adjusted for sex, season, mother’s education, 
age (time), sector of residence, maternal peripheral parasitemia, sickle cell genotype, and non-
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malarial anemia and non-malarial infection in the previous month. This model provided 
estimates for odds ratios comparing odds of malaria incidence or prevalence across different 
levels of stunting, under/overweight, and wasting. 
There were two types of missing data in the ABCP: completely missed visits where no 
data were collected on a child for a particular month, and missing data within completed visits, 
where some data were collected on a child in a particular month, but not all. Missing data may 
lead to biased estimates and/or standard errors To address these two types of missing data, 
multiple imputation methods were combined with inverse probability weighting methods to 
provide effect estimates that are potentially less biased than a complete case analysis.111 
To address missing data values within completed visits, multiple imputation by chained 
equations (MICE) was used for all variables included in the analysis.164 MICE is a flexible 
method of multiple imputation that allows for different imputation models for each variable 
with missing values. For each variable with missing data, 40 cycles of imputation were carried 
out before making one imputed dataset. In each cycle, each variable with missing values was 
regressed on all other variables and missing values were replaced by simulated draws from the 
posterior predictive distribution of the missing variable.112 A total of 50 separate datasets were 
imputed. Each variable in the analysis was used to predict all other variables with the following 
exceptions:  HAZ was used as a predictor for WAZ and vice versa, but neither was used as a 
predictor for WHZ due to collinearity concerns. See Tables 1 and 2 for information on which 
variables were imputed. 
In addition to the covariates and the outcome from the analysis model, other variables 
that predict the incomplete variables and whether they are missing (auxiliary variables) should 
also be included in the imputation models.112 Gestational age, birth rank, and mother’s height 
were chosen as auxiliary variables based on their association with either the exposure or the 
outcome, or missingness of the exposure or the outcome. All three were included as auxiliary 
variables for all models except for models imputing malaria variables and non-malarial anemia, 
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in which only gestational age and birth rank were used. To take advantage of the longitudinal 
structure of the models, for each time varying variable the two previous measurements and two 
following measurements were included as auxiliary variables.165,166 All Z-score variables were 
imputed as continuous variables using predictive mean matching models, which provides 
imputed values that are consistent with observed values.167 Malaria variables and non-malarial 
anemia were imputed as categorical/binary variables in their final analytic form using logistic 
models. Logistic models for non-malarial anemia and malaria variables used the data 
augmentation method to account for perfect prediction when the maximum likelihood 
parameter estimates did not exist. In this method the data are augmented with a small number 
of additional observations that are weighted to limit their impact on the imputation model. The 
addition of the augmenting variables averts perfect prediction and allows the imputation model 
to converge.168 The discriminant function method (the default method for classification 
variables)  was used to impute all other variables.169 Malaria outcome variables were included in 
the imputation models, but only observed outcomes were used in the final analysis models.170 
In the prevalence models, previous and concurrent malaria status may affect both 
current z-score (the primary exposure) and future malaria status (the primary outcome), making 
previous malaria status a time-varying confounder affected by prior exposure (see Figure 11). In 
the prevalence model (Figure 11), previous malaria may be on a causal path from previous z-
score at time t through malaria at time t1 to malaria at time t2 to the outcome at time t3 (arrows 
a, f and g). To remove potential bias due to time-varying confounding by previous malaria 
status, while also keeping all potential causal paths open (yellow arrows in Figure 11), inverse 
probability of exposure weights were used to remove the association between malaria at times t1 
and t2 with z-score at time t2 (arrows c and d in Figure 11) in the weighted analysis models. 
Likewise, the incident malaria models may also be confounded by previous malaria 
status affected by prior exposure (Figure 12). In the incident malaria models, we restricted the 
analysis to children with a current negative blood film (indicated by a box around malaria at 
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time t2). In this model, malaria at subsequent time points is only associated through U, an 
unmeasured confounder linking the likelihood of a previous malaria infection to future 
incidence, such as standing water outside the house. Malaria transmission is strongly associated 
with location, although the strength of this association decreases as transmission intensity 
increases.171 However, it has been shown that household location can be a predictor of variations 
in malaria incidence in children, even in high transmission areas.172 It’s important to consider 
that separate, incident malaria infections may be associated through an unmeasured confounder 
such as U. By including only children with a negative blood film at time t2 in the model, we open 
up a backdoor path from the exposure to the outcome through malaria at time t1 and U. To 
avoid potential bias introduced by previous malaria status, we again used inverse probability of 
exposure weights to remove the association between incident malaria at times t1 and t2 with z-
score at time t2 (arrows c and d).  
  
 
Figure 11: Directed acyclic graphs showing the 
relationship between Z-score and prevalent malaria 
 
Figure 12: Directed acyclic graphs showing the 
relationship between Z-score and incident malaria 
For both Figure 11and Figure 12: yellow lines are associations we want to estimate. Red lines are associations that will 
be removed through inverse probability of exposure weights. t is an indicator of time in months 
 
Three different inverse probability of exposure weights (IPEW) were created - one for 
each type of anthropometric exposure (HAZ, WAZ, WHZ). The use of IPEWs makes the 
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exposure in the weighted dataset independent of measured confounders, including previous and 
concurrent malaria status (see Figure 11 and Figure 12, times t1 and t2). IPEWs were calculated 
as the inverse probability of exposure to z-score deciles.113 Ordinal logistic regression was used 
to calculate the denominator of the weights as the probability of each child’s observed z-score 
decile in each month, conditional on all time-fixed covariates and time-varying covariates, 
including previous and concurrent malaria status. The weights were stabilized by the marginal 
probability of each child’s observed z-score decile, conditional on age. Weights were truncated at 
the 1st and 99th percentile.114  
To account for potential selection bias arising from missed visits, inverse probability of 
observation weights (IPOWs) were calculated with a logistic model for the inverse probability of 
completing a visit or having an observed outcome, conditional on predictors of completing a 
visit or having an observed outcome.173 Predictors included the following time-varying variables: 
observation history (a categorical indicator of months since last visit), exposure (HAZ, WAZ, 
and WHZ), age (modeled as a cubic variable, based on likelihood ratio tests), non-malarial 
infection, non-malarial anemia, and season. The following time-fixed variables were also used in 
the IPOW models: sex, residence, mother’s parasitemia, mother’s education and sickle cell 
genotype. Time varying variables were the last recorded value prior to the visit or outcome that 
was missed. IPOWs were stabilized by: observation history, exposure, age, and baseline 
covariates mentioned above. IPOWs were then combined with inverse probability of censoring 
weights (IPCWs), which addressed potential selection bias from right censoring at last study 
encounter due to dropout.136,174,175 Variables in the IPCW logistic model included: exposures 
(HAZ, WAZ, HWZ), age (modeled as a cubic variable, based on likelihood ratio tests), infection, 
non-malarial anemia, season, residence, mother’s education, mother’s parasitemia and sickle 
cell genotype. IPCWs were stabilized by exposures, time fixed covariates and age. Final analysis 
results were similar whether deaths were included or excluded from the IPCWs. The final IPCWs 
used in the analysis models do not include weighting for death. Administrative censoring was 
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not found to be differential with respect to the exposures or outcome, and therefore was also not 
included in the IPCWs. IPEWs, IPOWs and IPCWs were multiplied together into a final weight 
for each record and used to weight the final prevalence exposure-outcome model for the 
multiply imputed data.111 The weight used for each analysis was dependent on the exposure in 
each model (HAZ, WAZ or WHZ).  




The original study included 1,408 infants and siblings followed from birth through four 
years of age. The analysis sample was limited to the first infant from each mother enrolled in the 
study, and follow-up was stopped at 30 months, when only 20% of the original sample 
remained. This resulted in a sample of 1,182 children followed from age 0 to 30 months. Of 
these, 1,176 were enrolled within 5 months of birth, six were enrolled between 6-12 months, and 
one enrolled at 21 months. The mean age at the start of the study was 0.18 months (5.4 days) 
(standard deviation (SD)=0.94), and mean age at end of study (average follow-up time) was 16.4 
(SD=10.2) months. A total of 18,028 visits were recorded among the 1,182 children in the study, 
and 72% had at least one episode of clinical malaria, 79% had at least one episode of 
asymptomatic parasitemia, 60% had an episode of non-malarial anemia, and 92% had at least 
one non-malarial infection. Prevalent malaria analyses were limited to records with an observed 
malaria outcome, which included 13,240 visits on 1,119 children. Incident malaria analyses were 







Table 9: Asembo Bay Cohort Study, Time Fixed Characteristics, Nyanza Province, Kenya, 1992 – 1996 
Children 0-30 Months – Aim 1 
 Original Data N = 1,182 
 50 datasets with 
imputed Data 
N = 59,100 
Variable N (%) or Mean (SE) Missing (%)*  N (%) or Mean (SE) 
Sex 
 
0   
Male 598 (50.6) 
 
 29,900 (50.6) 
Female 584 (49.4) 
 
 29,200 (49.4) 
Age at Enrollment (days) 5.4 (28.2) 0  5.4 (28.2) 
SES (value of goods, animals and houses) 
 
4 (0.33)   
level 1 (lowest SES) 588 (49.9) 
 
 29,513 (49.9) 
level 2 (highest SES) 590 (50.1) 
 
 29,587 (50.1) 
Mother's education (years) 
 
4 (0.33)   
< 7 years 454 (38.5) 
 
 22,758 (38.5) 
>= 7 years 724 (61.5) 
 
 36,342 (61.5) 
Village residence (Sector) 
 
3 (0.25)   
1 380 (32.2) 
 
 19,047 (32.2) 
2 315 (26.7) 
 
 15,787 (26.7) 
3 283 (24.0) 
 
 14,183 (24.0) 
4 201 (17.1) 
 
 10,083 (17.1) 
Maternal peripheral parasitemia 
 
22 (1.9)   
Y 407 (35.1) 
 
 20,738 (35.1) 
N 753 (65.0) 
 
 38,362 (65.0) 
Sickle cell genotype 
 
173 (14.6)   
Homozygous (SS) 36 (3.6) 
 
 2,122 (3.6) 
Heterozygous (AS) 173 (17.2) 
 
 10,310 (17.5) 
Negative (AA) 800 (79.3) 
 
 46,668 (79.0) 
*The missing column indicates the number (%) of children for whom missing baseline data were imputed. Sex and 












Table 10: Asembo Bay Cohort Study, Time Varying Characteristics, Nyanza Province, Kenya, 1992 – 1996  
Children ages 0-30 months – Aim 1 (n=1,182) 
 
Observed Data 
Visits = 18,028 
 50 datasets with imputed Data 
Visits = 901,400 
Variable N (%) or Mean (SE) Missing (%)  N (%) or Mean (SD) 
Height-for-age Z score -1.57 (0.01) 4,934 (27.4)  -1.61 (0.01) 
Weight-for-age Z score -0.45 (0.01) 4,353 (24.2)  -0.46 (0.01) 
Weight-for-height Z score 0.63 (0.01) 5,073 (28.1)  0.63 (0.01) 
Non-malarial Illness* 5,225 (37.5) 4,106 (22.8)  414,982 (46.0) 
Non-malarial Anemia* 1,434 (10.5) 4,342 (24.1)  152,618 (16.9) 
Clinical Malaria Prevalence 3,123 (21.3) 3,375 (18.7)  - 
Asymptomatic Parasitemia Prevalence 6,365 (43.4) 3,375 (18.7)  - 
Clinical Malaria Incidence 1,400 (9.6) 3,375 (18.7)  - 
Asymptomatic Parasitemia Incidence 2,452 (16.7) 3,375 (18.7)  - 
Outcome data (malaria variables) were imputed but not used in the final outcome models. The missing column 
indicates the number (%) of visits for which data were imputed. 
* Non-malarial anemia and non-malarial illness were measured in the month prior to the exposure.  
 
Missing Data 
Multiple imputation was used to impute missing values for the following baseline 
variables: Residence sector, maternal peripheral parasitemia, maternal education, SES, and 
sickle cell genotype (see Table 9). Among completed visits, the following time-varying variables 
were also imputed: non-malarial infection, non-malarial anemia, HAZ, WAZ, and WHZ (see 
Table 10). Sex, age and season were complete variables and were not imputed. Time-fixed (Table 
9) and time-varying (Table 10) study sample characteristics, including the percentage of missing 
variables that were imputed, and the distribution of imputed variables are presented above. 
IPOWs were calculated to account for 2,338 (11%) missed visits and 4,788 (24%) visits 
with missing outcome data (IPOWs accounted for a total of 7,126 (35%) missed visits). Of the 
1,182 study subjects, 501 (42%) terminated participation prior to age 30 months or the end of 
the study and 209 (18%) died. IPCWs were calculated to account for right censoring due to 
dropout among all 18,028 visits. IPCWs did not account for loss to follow-up due to death. 
Results of the final analysis models did not differ significantly when deaths were included. The 
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In general, there was not a strong association between any type of malnutrition and 
either prevalent or incident malaria. Odds ratios for the association of stunting or underweight 
on prevalent and incident malaria were higher for asymptomatic parasitemia than for clinical 
malaria. This trend was more pronounced in the prevalence models. The association between 
stunting or underweight and prevalent asymptomatic parasitemia also showed a modest dose 
response, with prevalence odds ratios increasing as Z-score decreased. See Figure 13.  
Reported results are from the weighted, imputed data analysis. The complete case 
analysis models were only slightly further from the null than the weighted, imputed data 
analysis (data not shown). These differences were not significant. Alternate time lags between 
the exposure and the outcome of two and three months were also explored. The results from 
these models were attenuated toward the null and have not been reported here. 
Across both incident and prevalent malaria models there was a modest association 
between stunting and underweight and asymptomatic parasitemia. The effects were slightly 
larger in the prevalence models. The prevalence odds ratio (POR) for the association between 
severe or moderate stunting (HAZ) and prevalent asymptomatic parasitemia in the following 
month was: severe = 1.35 (95% confidence limit (CL): 1.03, 1.76); moderate = 1.20 (95% CL: 
0.95, 1.53). The POR for the association between moderate or mild WAZ and subsequent 
prevalent asymptomatic parasitemia was: moderate = 1.35 (95% CL: 1.09, 1.66); mild = 1.16 
(95% CL: 1.02, 1.33). The OR for the association between stunting and incident asymptomatic 
parasitemia was: severe = 1.31 (95% CL: 0.93, 1.85) and moderate= 1.28 (95%CL: 0.95, 1.74). 
For underweight the OR for incident asymptomatic parasitemia was: moderate= 1.43 (95% CL: 






Figure 13: Associations between height-for-age, weight-for-age or weight-for-height Z-score categories and 
prevalent and incident malaria outcomes in the following month. 
Odds ratios are from multiply imputed data with observed outcomes analyzed with weighted GEE models. Prevalence 
models are shown in column 1, N = 1,119. Incidence models were limited to observations with a negative malaria film 




There was no significant association between any category of wasting and prevalent or 
incident malaria in the following month. There was also no association seen between any type of 
malnutrition and either type of clinical malaria in the following month (prevalent or incident).  
 
Discussion 
Using data from the Asembo Bay Cohort Project in Western Kenya, we found that 
stunting and underweight were associated with slightly increased odds of subsequent prevalent 
and incident asymptomatic parasitemia in children under 30 months. However, there was no 
evidence of an association between any measure of malnutrition and either type of clinical 
malaria in the following month, nor was there an association between wasting and any type of 
incident or prevalent malaria. 
The null association between malnutrition and clinical malaria is consistent with the 
majority of previous longitudinal studies, which also found that malnutrition did not increase 
the risk of clinical malaria.70,72–76 Two previous studies did find an increased incidence of clinical 
malaria among stunted (moderate-severe) children compared to non-stunted children.68,69 
However, neither adjusted for non-malarial infections, which may modulate the response to 
malaria.176 Additionally, both could be subject to reverse causality bias given that exposures 
were either measured at the same time as the outcome,69 or only at baseline (and therefore 
might have changed during the follow-up period)68.  
There are few previous studies on the association between malnutrition and 
asymptomatic parasitemia. Three studies showed an association between stunting and 
concurrent asymptomatic parasitemia, and two studies found no association. An increased odds 
ratio for asymptomatic parasitemia, although not for clinical malaria, was an unexpected finding 
in this study. A later cross sectional study conducted in the same region among children who 
received ITNs also found a higher odds ratio for the association between moderate stunting and 
concurrent asymptomatic parasitemia (1.98) than for stunting and clinical malaria (1.77). The 
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same study also found increased odds ratios (above the effect estimate for clinical malaria) for 
severe malarial anemia and high density parasitemia when comparing moderately stunted 
children to all others.47 
It is unclear why underweight and stunted children in this population would have 
increased odds of asymptomatic infection, but not clinical infection. The paucity of previous 
research with asymptomatic infections as an outcome makes it difficult to determine if this was 
a regularly occurring phenomenon within areas of intense malaria transmission, or something 
particular to this population. The relationship between malnutrition and malaria is complex, 
and findings from other studies are potentially dependent on the epidemiology of malaria and 
the determinants of malnutrition specific to each study population.  Nevertheless, we can 
develop hypotheses based on our current knowledge of the immune system among children with 
malnutrition. One possible explanation may be immune dysfunction among chronically 
malnourished children. There is limited research on the effects of malnutrition on the immune 
system, including the development of fever. A recent review highlighted that the TH1 
inflammatory response and number of activated dendritic cells tend to be reduced in 
malnourished children compared to well-nourished, while the TH2 response is increased in 
moderately malnourished children.177 A lowered response by TH1 cytokines and dendritic cells 
among chronically malnourished children could potentially lead to a reduced febrile response to 
malaria parasites in this group, resulting in higher odds of asymptomatic parasitemia.  
Alternatively, immune exhaustion may play a role in increasing odds of asymptomatic 
parasitemia among stunted and underweight children. Fontana discussed the role that 
exhausted T cells may play in asymptomatic parasitemia. She suggests that these exhausted T 
cells may be mediators of the relationship between the host and the pathogen during chronic 
infection, whereby exhausted T cells fail to clear the infection yet can limit the parasite load to 
avoid “overwhelming pathology to the host.” 178 Chronic malnutrition such as stunting or 
underweight may have a larger effect on asymptomatic parasitemia rather than clinical malaria 
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if malnourished children are more likely to experience immune exhaustion placing them at 
higher risk of asymptomatic parasitemia whereby the parasites are regulated by exhausted T 
cells.  
The wasting exposure models did not show an association with subsequent incident or 
prevalent malaria. This is consistent with the majority of longitudinal studies that also found no 
association between wasting and malaria outcomes.46,68,73,74,76 Wasting and stunting represent 
different forms of malnutrition. Wasting represents acute malnutrition, often occurring over a 
short period of time, while stunting represents chronic malnutrition, developing over a longer 
period of time. These different forms of malnutrition may have different effects on the immune 
response to malaria. When comparing malnourished children to non-stunted or wasted 
controls, Fillol, et al. found the adaptive immune response to malaria was significantly lower in 
stunted children but did not see this effect in wasted children.53 No studies have specifically 
investigated the effect of malnutrition on the innate immune response to malaria. Our study 
only investigated the association of moderate wasting (WHZ <= -2) with subsequent malaria 
outcomes, due to a limited number of children with severe wasting (WHZ <= -3). It is possible 
that severe wasting could show an association with subsequent malaria, due to the effects severe 
wasting can have on immune function and its association with increased mortality.179   
 
Strengths and Limitations 
This study had several strengths and limitations. Strengths included a large sample of 
children followed from birth with data on both clinical malaria and asymptomatic parasitemia, 
biweekly blood collections, monthly anthropometric measurements, and the availability of a 
wide-ranging set of potential confounders to use in multivariable models. Although the dataset 
is older, the higher incidence of malaria that occurred in this study population compared to 
current populations likely provided the study provide greater power to detect these associations 
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than a similar study conducted in a present day population benefiting from broad scale-up of 
both preventive and curative malaria interventions. 
The age of the dataset makes the study less generalizable to most current populations 
across Africa. The current epidemiology of malaria in western Kenya may be different that that 
experienced by this cohort. Since 2000, incidence of malaria in Kenya has decreased from 
237.7/1,000 people at risk to 166/1,000 and the prevalence of children sleeping under ITNs has 
increased from 3% to 56.1%.180 Associations detected between malnutrition and malaria in this 
1992-96 dataset may not necessarily represent associations that currently exist in western Kenya 
if the relationship between malaria and nutrition is influenced by the specific epidemiology of 
malaria. Additionally, differences in historic and current malaria treatment may also make the 
findings less generalizable. The close follow up of participants, prompt diagnosis and treatment 
with Fansidar, and protocol for treatment failures (Halofantrine) should have ensured that all 
children were treated adequately for malaria, while minimizing and managing any treatment 
failures during this era of decreased chloroquine efficacy.181  
There have also been improvements in health and nutrition status of children under five 
over the past 25 years. From 1998 to 2014, the prevalence of stunting in Kenya decreased from 
37% to 26%. Likewise, optimal child feeding practices such as exclusive breastfeeding have 
improved.30,182 As children’s health and nutrition has improved, and malaria incidence has 
declined, the relationship between malnutrition and malaria may have changed. Proximal 
determinants of malnutrition may have changed with improvements in nutrition practices and 
sanitation, which may, in turn, have an effect on children’s immune systems, rendering them 
more or less susceptible to malaria. Likewise, changes in the epidemiology of malaria, such as 
increasing age of acquired immunity, and decreasing attack rates may change how 
malnourished children respond to malaria. 
This study used low hemoglobin as a proxy for iron deficiency anemia. Low hemoglobin 
can be caused by iron deficiency, but also by various infections and other nutritional 
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deficiencies, and is not an ideal proxy for iron deficiency anemia. However, we increased the 
specificity of low hemoglobin as a marker for iron deficiency by excluding anemia caused by 
malaria, and controlling for sickle cell disease. Most previous studies of the relationship between 
malnutrition and subsequent malaria did not control for iron deficiency anemia.68–71,73,75 The 
inclusion of the proxy measure as a confounder, although not an ideal measure, is an 
improvement over previous research. 
The high proportion of missing data in this study is a limitation. Measures were taken to 
minimize bias due to missing data and dropout, which included multiple imputation and the use 
of inverse probability weights to account for missed visits and dropout. However, if missingness 
was due to unobserved variables that were also associated with the exposure or the outcome, 
then selection bias may still be present. 
HIV may be a confounder of the relationship between both growth faltering and malaria, 
and data on HIV status was not available for this study. Prevalence of HIV among pregnant 
women at the time of the study was estimated at 30%.126 HIV may increase prevalence of clinical 
malaria in children115 or increase parasite density.183 If children with HIV were more likely to 
have asymptomatic parasitemia and be underweight or stunted, the odds ratios may have been 
biased away from the null. However, if HIV was associated with a measured confounder (such as 
non-malaria infection, SES, or mother’s education) conditional on the exposure, confounding 
bias due to HIV may have been partially controlled by these other variables.184 The relationship 
between stunting and malaria has previously been shown to be consistent across HIV infected 
and uninfected children.69 Given the demonstrated independence of the malnutrition-malaria 
relationship from HIV status and the potential for residual control by included covariates, the 
results of this study are unlikely to be significantly biased by unmeasured confounding from 
HIV. 
The potential cyclical nature of the relationship between malnutrition and malaria makes 
epidemiologic research on this topic challenging. Malnutrition may increase risk of malaria, 
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while malaria may also increase risk of malnutrition. The use of IPEWs to adjust for time 
varying confounding affected by prior exposure allowed for an estimation of the association 
while preventing potential reverse causality bias due to prior malaria infection. The use of these 
methods makes this study a novel addition to the literature on this complex relationship. The 
similarities between the complete case analysis and the imputed, weighted model indicate that 
missing data and time varying confounding were not a large source of bias in this population. 
 
Conclusions 
Stunting and underweight do not show an association with clinical malaria but they do 
show a limited association with asymptomatic parasitemia in the month following the exposure. 
This association was seen even in mildly underweight children. Current malaria control efforts 
may consider prioritizing test and treat strategies for specific populations of children at greater 
risk of stunting and underweight. Malaria testing for stunted and underweight children in 









CHAPTER 5: AIM 2 - LIMITED ASSOCIATION BETWEEN CUMULATIVE 
EPISODES OF MALARIA AND LINEAR GROWTH AMONG CHILDREN UNDER 
THREE IN KENYA 
 
Introduction 
Despite consistent reductions in malaria infections over the past 20 years, malaria 
remains a leading cause of death for children under five both globally185 and especially in Africa, 
where it was the fourth leading cause of death in 2015.1  According to the most recent World 
Malaria Report, gains in malaria control stalled between 2015 and 2017, and 13 countries saw an 
increase in malaria infections in 2017.2 Malnutrition and poor growth also continue to affect a 
high proportion of children worldwide, especially in malaria endemic regions. One quarter of 
children under five globally, and over one third of children in East Africa, are stunted.182 The 
long term effects of malnutrition include: increased risk of death,21 earlier onset and increased 
risk of non-communicable diseases, impaired cognitive development,24 increased incidence of 
depression,19 decreased school attainment,25–27 and forgone wages and decreased labor 
productivity.28  
Malaria and malnutrition primarily afflict children under five in similar geographic 
locations. However, the relationship between the two is still not well understood.186  The 
association between malaria and malnutrition may be bi-directional. The potential cyclical 
nature of the relationship makes research on this topic challenging. Malnutrition may increase 
susceptibility to malaria or may be more likely to occur after one (or many) malaria infections. 
Most previous research has focused on whether malnutrition predisposes children to increased 
risk of subsequent malaria.69–74 In a previous study we looked at the relationship between 
malnutrition and subsequent malaria infections (manuscript in progress). We found that while 
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malnutrition was not associated with subsequent clinical malaria, prior stunting and 
underweight were associated with increased odds of asymptomatic parasitemia. 
Research on the reverse question – whether malaria may affect subsequent growth in 
children – is limited. Multiple malaria infections may reduce growth by altering intake, 
absorption and use of nutrients due to chronic inflammation.  Results from observational 
studies in p. falciparum endemic areas on the association between malaria infection and 
subsequent growth status in children have been mixed. Some studies have shown that clinical 
malaria (defined as diagnostically confirmed parasites with,68,75,93,95,187,188 or without 94 fever) can 
lead to limited growth deficits in children, either in weight gain (underweight)93,187 or height 
(stunting).75,92–95,187 Others have shown no association between baseline malaria and subsequent 
growth status,68,188  including a recent systematic review.139 Insecticide treated net (ITN) 
intervention studies have largely shown that ITN distribution results in increased weight and 
height gains,86–89 although one study concluded that ITNs had no effect on growth status.90   
Discrepancies in results may be due to variations in study design, including varying control for 
confounding, methodological differences in assessing growth status or malaria infection, and 
discrepancies in the study population or location such as malaria transmission intensity or 
variations in the host-parasite relationship. Inconsistencies may also be due to differences in the 
epidemiology of both malnutrition and malaria which may have developed following intensive 
scale up of interventions to prevent both over the past 25 years. Some previous studies were 
conducted prior to the widespread use of interventions such as ITNs, indoor residual spraying, 
and treatment with artemisinin-based combination therapy (ACT),68,93,187 while others have been 
conducted since their implementation.75,94,95,188    
The purpose of this study was to assess the association between cumulative months of 
incident clinical malaria and cumulative months of prevalent parasitemia on subsequent height-
for-age and weight-for-height Z-scores in children under 30 months. We hypothesized that 
multiple malaria infections or persistent parasitemia in children may lead to consistent 
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diversion and loss of nutrients, contributing to growth faltering and sustained undernutrition. 
The most recent World Malaria Report indicated that progress on malaria control has stalled.2 
At the same time, the absolute number of stunted children in Africa continues to increase.20 
Clarifying the relationship between malaria and malnutrition and how the two interact remains 
a priority. Using data from an older study that were collected during an era of increased 
prevalence of malaria and malnutrition allows for a study with greater power to detect 
associations than a current study would have. Results from this study may be used to clarify the 
relationship between malnutrition and malaria for public health practitioners and to help define 




Data for this study come from the Asembo Bay Cohort study conducted in 15 villages in 
the Asembo Bay area of Siaya District in Nyanza Province, western Kenya between 1992 and 
1996. The study was designed to assess the epidemiology, entomology, immunology, host 
factors, molecular biology, antigenic variation, and population genetics of P. falciparum in a 
large cohort of women and children in an area with intense malaria transmission. Malaria was 
holoendemic in the study site, with an estimated entomologic inoculation rate of 0.75 infective 
bites per person per day.96 This area has two rainy seasons from March to May and October to 
December, and two dry seasons from January to February and June to September. Chloroquine 
was the only malaria intervention available at local health facilities during the study period.144  
Beginning in June 1992, all pregnant women in participating villages were identified 
during a monthly census by trained community health workers or birth attendants who lived in 
the same village. They provided informed consent and were visited every month at home by 
village monitors who administered standard questionnaires and obtained axillary temperatures, 
thick and thin blood smears and capillary blood samples. Mother-infant pairs were visited 
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within two weeks of birth and then every two weeks thereafter. At each visit questionnaires were 
administered and the children’s health was reported by the mother or an adult sibling or 
guardian. Axillary temperatures were obtained using a digital thermometer. Capillary blood, 
thick and thin blood smears, and anthropometric measures were collected once per month. 
Height and weight were measured in centimeters and kilograms (respectively) to the nearest 
10th. Children who were old enough to stand were measured standing, all others were measured 
recumbent. Any participant with documented fever and malaria parasitemia received a 
treatment dose of sulfadoxine/pyrimethamine (SP).  More severe illnesses were referred to local 
health facilities. Mother-infant pairs were followed until loss to follow-up, death, end of the 
study, or the infant’s fifth birthday.97 
All blood smears were stained with Giemsa and parasite densities were quantified by 
counting the number of asexual parasites per 300 leukocytes. Parasite density was calculated 
assuming a leukocyte count of 8,000/mm.134 Hemoglobin was measured using the HemoCue 
system (HemoCue, Anglholm, Sweden).98 Hemoglobin genotyping was done retrospectively 
using a polymerase chain reaction method.99 Additional information regarding laboratory 
procedures and data collection has been described in the literature.97 
 
Measures 
Cumulative incident clinical malaria 
Clinical malaria was defined as the presence of any parasites with fever (axillary 
temperature ≥ 37.5°C). Each episode of clinical malaria was considered an incident infection if 
the previous month showed no parasites. Monthly incident clinical malaria episodes were 
summed from birth through the current record to create a discrete, ordinal, cumulative clinical 





Cumulative prevalent clinical malaria 
Prevalent clinical malaria was also investigated as an exposure. For this discrete, ordinal 
variable, each month with documented clinical malaria was summed from birth through the 
current record (regardless of the previous month’s malaria status). 
Cumulative parasitemia 
Parasitemia was defined as the presence of any malaria parasites, with or without fever. 
Each month with documented parasitemia was summed from birth through the current record 
to create a discrete, ordinal, cumulative prevalent parasitemia variable. 
Based on the bivariate relationship between each cumulative exposure and the outcome, 
ordinal variables were collapsed at four episodes for incident clinical malaria, six months for 
prevalent clinical malaria, and ten months for prevalent parasitemia. 
Anthropometrics 
Continuous Z-scores comparing a child’s height-for-age (HAZ), weight-for-age (WAZ),  
or weight-for-height (WHZ) to a reference population were calculated using WHO’s Multi 
Centre Growth Reference Study.100 Z-scores were calculated assuming heights were measured 
for children two years and older, and lengths for children under two years. If more than two 
height and weight measurements were made within a one month period, the Z-scores for these 
measurements were averaged together. HAZ and WHZ were used as the main exposures, while 
WAZ was investigated as an exposure in a secondary analysis. 
Z-scores that were outside plausible bounds were flagged and changed to missing, 
according to the following guidelines defined by WHO:100 height-for-age Z-score less than -6 or 
greater than 6; Weight-for-age Z-score less than -6 or greater than 5; weight-for-height Z-score 
less than -5 or greater than 5. Accordingly, 215 (0.5%) HAZ, 54 (0.1%) WAZ, and 223 (0.5%) 
WHZ measurements were flagged and changed to missing. 
A method to visually assess plausibility of height measurements was defined based on 
previously described methods.101 Height measurements for each child were graphed over time 
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and flagged for visual inspection if they indicated a decrease from the previous measure of more 
than two cm. Flagged heights that appeared as a "divot," deviating from the height trend, were 
discarded if the following point returned to the original length trend. The previous height was 
discarded if it appeared as a “peak,” where it deviated above the height trend, and the following 
height returned to the original trend. The last height measurement on a child was not flagged for 
missing unless it was clear there was a loss of height from a consistent height trend in the 
previous measurements. If no immediate trend could be seen in the measurements before or 
after the flagged height, the flagged measurement remained in the data. 1,057 (6%) height 
measurements were flagged and visually inspected, and 847 (<5%) were discarded.  
Covariates 
Covariates were identified from a directed acyclic graph145 informed by the literature. 
Time varying covariates included non-malarial anemia,32,146,147 season,134,148,149 age,134 and non-
malarial infection.57,78,150 Non-malarial anemia was defined as a dichotomous variable indicating 
any anemia (<110 g/l hemoglobin) occurring without a concurrent parasite density (density = 
0), and not within one month of a clinical malaria infection. This was assessed in the month 
prior to the exposure.  This variable was included as a proxy for iron-deficiency anemia, which 
may be a confounder of the relationship between malnutrition and malaria. However, given the 
numerous causes of anemia in this population, the effectiveness of this variable as a proxy for 
iron deficiency anemia may be limited. Season was a three level indicator variable denoting dry, 
rainy and transition months. Non-malarial infection was a dichotomous variable assessed in the 
month prior to the exposure indicating inability to drink, experience of chills, diarrhea, 
vomiting, difficulty breathing, or fever, in the absence of malaria parasitemia. Time was 
calculated as months from birth and modeled as a linear term (based on the quasi Akaike 
information criterion (QIC) comparing multiple functional forms).151  
Time-fixed covariates included child sex,152 mother’s education,153,154 SES,155,156 residence 
sector,157–159 maternal peripheral parasitemia160,189 and sickle cell genotype.162,163 Mother’s 
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education was a dichotomous variable indicating less than seven years of schooling or seven 
years or more. SES was a dichotomous variable based on three indicators: ownership of more 
than one building within a compound, ownership of a bicycle and ownership of a pressure lamp, 
based on perceptions of residents in the study area at the time of data collection.97 Villages were 
grouped into four different sectors and coded as indicator variables. Maternal peripheral 
parasitemia density was a dichotomous variable indicating presence or absence of peripheral 
blood parasitemia at delivery. Sickle cell genotype was coded as indicator variables (HbAA – 
negative or HbAS – sickle cell trait, or HbSS – sickle cell disease).  
Auxiliary Variables 
Auxiliary variables that were used in the multiple imputation model included mother’s 
height, birth rank and gestational age. Mother’s height was a dichotomous variable indicating 
less than 158cm or 158cm or more. Birth rank was a dichotomous variable indicating the child’s 
rank at birth (singleton or twin). Gestational age was an ordinal variable indicating weeks of 
gestational age at birth. 
 
Statistical Analysis 
Linear generalized estimating equation (GEE) models with an exchangeable working 
covariance correlation structure with inverse probability weights were used to estimate the 
association between Z-score measured one month after cumulative malaria while accounting for 
repeated observations on the same children.107 These models were adjusted for age and time 
fixed covariates, allowing for an interaction between the exposure and age. Time varying 
confounders were accounted for through inverse probability of exposure weights. These models 
provided estimates for the mean difference in HAZ or WHZ, following a one episode change in 




There were two types of missing data in the ABCS: completely missed visits where no 
data were collected on a child for a particular month, and missing data within completed visits, 
where some data were collected on a child in a particular month, but not all. Missing data may 
lead to biased estimates and/or standard errors To address these two types of missing data, 
multiple imputation methods were combined with inverse probability weighting methods to 
provide effect estimates that are potentially less biased than a complete case analysis.111 
To address missing data values within completed visits, multiple imputation by chained 
equations (MICE) was used for all variables included in the analysis.164 MICE is a flexible 
method of multiple imputation that allows for different imputation models for each variable 
with missing values. For each variable with missing data, 40 cycles of imputation were carried 
out before making one imputed dataset. In each cycle, each variable with missing values was 
regressed on all other variables and missing values were replaced by simulated draws from the 
posterior predictive distribution of the missing variable.112 A total of 40 separate datasets were 
created. Each variable in the analysis was used to predict all other variables with the following 
exceptions:  HAZ was not used to predict WHZ and vice versa due to collinearity concerns. 
In addition to the covariates and the outcome from the analysis model, other variables 
that predict the incomplete variables and whether they are missing (auxiliary variables) should 
also be included in the imputation models.112 Gestational age, birth rank, and mother’s height 
were chosen as auxiliary variables based on their association with either the exposure or the 
outcome, or missingness of the exposure or the outcome. All three were included as auxiliary 
variables for all models except for models imputing malaria variables and non-malarial anemia, 
in which only gestational age and birth order were used. WAZ was also used as an auxiliary 
variable for HAZ. To take advantage of the longitudinal structure of the models, for each time 
varying variable the two previous measurements and two following measurements were 
included as auxiliary variables.165,166 Z-score variables were imputed as continuous variables 
using predictive mean matching models, which provides imputed values that are consistent with 
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observed values.167 Malaria variables and non-malarial anemia were imputed as 
categorical/binary variables using logistic models. Logistic models for non-malarial anemia used 
the data augmentation method to account for perfect prediction when the maximum likelihood 
parameter estimates did not exist. In this method the data are augmented with a small number 
of additional observations that are weighted to limit their impact on the imputation model. The 
addition of the augmenting variables averts perfect prediction and allows the imputation model 
to converge.168 The discriminant function method, (the default method for classification 
variables)  was used to impute all other variables.169 Anthropometric Z-score outcome variables 
were included in the imputation models, but only observed outcomes were used in the final 
outcome models.170 
When considering the relationship between cumulative malaria and subsequent HAZ or 
WHZ, previous Z-score may be affected by previous malaria infection, but also may affect both 
future malaria incidence or prevalence (the exposure) and future Z-score (the outcome), making 
previous Z-score a time varying confounder affected by prior exposure (see Figure 14). Previous 
Z-score at time t1 may be on a causal path from malaria at time t to the outcome at time t3 
(arrows a and e). To remove potential bias due to time-varying confounding by previous Z-score, 
while also keeping all potential causal paths open (yellow arrows in Figure 14), inverse 
probability of exposure weights were used to remove the association between Z-score at time t1 





Figure 14: Directed acyclic graphs showing the relationship 
between cumulative malaria and Z-score. Yellow lines are 
associations we want to estimate. Red lines are associations that will 
be removed through inverse probability weighting.  
 
Three different inverse probability of exposure (IPEW) weights were created, one for 
each type of exposure (cumulative incident clinical malaria, cumulative prevalent clinical 
malaria, and cumulative prevalent parasitemia). Inverse probability of exposure weights 
(IPEWs) were calculated as the inverse probability of exposure to either cumulative incident 
clinical malaria quartiles, cumulative prevalent clinical malaria deciles, or cumulative 
parasitemia deciles.113 Ordinal logistic regression was used to calculate the denominator of the 
weights as the probability of each child’s observed malaria quartile or decile at each time point, 
conditional on all time fixed covariates and time varying covariates, including prior HAZ and 
WHZ, which were modeled with restricted quadratic splines with knots at -2, 0 and 2.114 Age was 
modeled as a cubic variable. The weights were stabilized by the marginal probability of each 
child’s observed cumulative malaria quartile or decile, conditional on age and all time fixed 
covariates.  
To account for potential selection bias arising from missed visits, inverse probability of 
observation weights (IPOWs) were calculated with a logistic model for the inverse probability of 
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completing a visit or having an observed outcome, conditional on predictors of completing a 
visit or having an observed outcome.173 Predictors included the following time varying variables: 
observation history (a categorical indicator of months since last visit), exposure (malaria 
modeled as a categorical variable indicating no parasites, parasites without fever, or parasites 
with fever), age (modeled as a cubic variable), non-malarial infection, non-malarial anemia, and 
season. The following time fixed variables were also used in the IPOW models: sex, residence, 
mother’s parasitemia, mother’s education and sickle cell genotype. Time varying variables were 
the last recorded value prior to the visit or outcome that was missed. IPOWs were stabilized by: 
observation history, the exposure, and age. Two different sets of IPOWs were calculated, one for 
children with missing HAZ, and one for children with missing WHZ. IPOWs were then 
combined with inverse probability of censoring weights (IPCWs), which addressed potential 
selection bias from right censoring at last study encounter due to dropout.136,174,175 Variables in 
the IPCW logistic model included: exposures (categorical malaria variable), age (modeled as a 
cubic variable), non-malarial infection, non-malarial anemia, season, residence, mother’s 
education, mother’s parasitemia and sickle cell genotype. IPCWs were stabilized by the exposure 
and age. Final analysis results were similar whether deaths were included or excluded from the 
IPCWs. Weighted results presented in this paper did not include weights for deaths, and are 
therefore conditional on survival. Administrative censoring was not found to be differential with 
respect to the exposures or outcome, and therefore was also not included in the IPCWs. IPEWs, 
IPOWs and IPCWs were combined into a final weight for each record and used to weight the 
final exposure-outcome model for the multiply imputed data.111 The weight used for each 
analysis was dependent on the exposure and outcome for each model.  
 
Secondary Analyses 
After reviewing the results for HAZ and WHZ outcomes we were curious about the effect 
of cumulative malaria on WAZ. WAZ was not a part of our original analysis plan, and was not 
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included in the imputation models. We therefore conducted one secondary analysis on the 
observed data only, investigating the effect of cumulative malaria on WAZ. Unweighted linear 
GEE models were used to estimate the difference in mean Z-score (HAZ, WAZ or WHZ) 
associated with a one month increase in cumulative incident clinical malaria or cumulative 
prevalent parasitemia in the observed data. These models were adjusted for sex, season, 
mother’s education, age (time), residence sector, maternal peripheral parasitemia, sickle cell 
genotype, non-malarial anemia and non-malarial infection, allowing for interaction of the 
exposure with age.  
All analyses were conducted in SAS version 9.4 (SAS Institute, Cary, NC). 
 
Results 
Study Population  
The original study included 1,408 infants and siblings who were followed from birth 
until five years of age. The analysis sample was limited to the first infant from each mother 
enrolled in the study, and follow-up was stopped at 30 months, when only 20% of the original 
sample remained. This resulted in a sample of 1,182 children who were followed from age 0 to 
30 months. Of these, 1,176 were enrolled within 5 months of birth, six were enrolled between 6-
12 months, and one enrolled at 21 months. The mean age at the start of the study was 0.18 
months (5.4 days) (standard deviation (SD)=0.94), and mean age at end of study (average 
follow-up time) was 16.4 (SD=10.2) months. A total of 18,028 visits were recorded among the 
1,182 children in the study, and 72% had at least one episode of clinical malaria, 79% had at least 
one episode of parasitemia, 60% had an episode of non-malarial anemia, and 92% had at least 
one non-malarial infection. Incidence and prevalence rates for malaria infections in the study 
population were: 0.078 episodes of incident clinical malaria per person month; 0.17 episodes of 
prevalent clinical malaria per person month; 0.53 episodes of any parasitemia per person 
month. All analyses were limited to records with an observed outcome. For HAZ this included 
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11,861 visits from 1,112 children and for WHZ it included 11.767 visits from 1,109 children. The 
secondary analysis on WAZ included 12,283 visits from 1,110 children. See Table 11 for baseline 
study characteristics and Table 12 for time varying sample characteristics. 
In the observed data, cumulative incident clinical malaria ranged from 0-7 (Interquartile 
range (IQR)=2), cumulative prevalent clinical malaria ranged from 0-17 (IQR=3) and 
cumulative prevalent parasitemia ranged from 0-29 (IQR = 9).  
 
Missing Data 
Multiple imputation was used to impute missing values for the following baseline 
variables: Residence sector, maternal peripheral parasitemia, maternal education, SES, and 
sickle cell genotype. Among completed visits, the following time varying variables were also 
imputed: infection, non-malarial anemia, and categorical malaria. Sex, age and season were 
complete variables and were not imputed. 
IPOWs were calculated to account for 2,338 missed visits and 6,167 visits with missing 
HAZ outcome data, for a total of 8,505 (42%) visits missing from the HAZ outcome models. A 
second set of IPOWs were calculated to account for 2,338 missed visit and 6,261 visits with 
missing WHZ outcome data, for a total of 8,599 (42%) visits missing from the WHZ outcome 
models. Of the 1,182 study subjects, 501 (42%) terminated participation prior to age 30 months 
or the end of the study. IPCWs were calculated to account for right censoring due to dropout, 
among all 18,028 visits. Results were unchanged when deaths were included in the calculation 
of IPCWs. The combined final weights were well behaved, with means close to 1 and range not 








Table 11: Asembo Bay Cohort Study, Time Fixed Characteristics, Nyanza Province, Kenya, 1992 – 1996 – Aim 2 
 Original Data N = 1,182 
 40 datasets with 
imputed data 
N= 47,280 
Variable N (%) or Mean (SD) 
Missing datapoints that 
were imputed (%) 
 
N (%) or Mean (SD) 
Sex 
 
0   
Male 598 (50.6) 
 
 23,920 (50.59) 
Female 584 (49.4) 
 
 23,360(49.4) 
Age at enrollment (days)* 5.4 (28.2) 0  11 (8.4) 





level 1 (lowest SES) 588 (49.9) 
 
 23,631 (50.0) 
level 2 (highest SES) 590 (50.1) 
 
 23,649 (50.0) 
Mother's education (years) 
 
4 (0.33)   
< 7 years 454 (38.5) 
 
 18,197 (38.5) 
>= 7 years 724 (61.5) 
 
 29,083 (61.5) 
Village residence (Sector) 
 
3 (0.25)   
1 380 (32.2) 
 
 15,234 (32.2) 
2 315 (26.7) 
 
 12,626 (26.7) 
3 283 (24.0) 
 
 11,349 (24.0) 
4 201 (17.1) 
 
 8,071 (17.1) 
Maternal peripheral parasitemia 
 
22 (1.9)   
Y 407 (35.1) 
 
 16,558 (35.0) 
N 753 (65.0) 
 
 30,722 (65.0) 
Sickle cell genotype 
 
173 (14.6)   
Homozygous (SS) 36 (3.6) 
 
 1,776 (3.8) 
Heterozygous (AS) 173 (17.2) 
 
 83,16 (17.6) 
Negative (AA) 800 (79.3) 
 
 37,188 (78.7) 





Table 12: Asembo Bay Cohort Study, Time Varying Characteristics, Nyanza Province, Kenya, 1992 – 1996 
Aim 2 
 
Original Data, Visits = 18,028 
40 Datasets with imputed 
data, Visits = 721,120  
Variable 
N (%) or 
Mean (SD) 
Missing datapoints 
that were imputed  (%) N (%) or Mean (SE) 
Height-for-Age Z-score (HAZ) #  (mean) -1.62 (1.46) 4,934 (27.4) - 
Weight-for-Height Z-score (WHZ) # (mean)  0.65 (1.44) 5,073 (28.1) - 
Weight-for-Age Z-score (WAZ) # (mean) -0.46 (1.33) 4,353 (24.2)  
Non-malarial Anemia$ 1,434 (10.5) 4,342 (24.1) 101,121 (14.0) 
Non-malarial Illness$ 5,225 (37.5) 4,106 (22.8) 278,173 (38.6) 
Incident Clinical Malaria 1,399 (8.8) 2,082 (11.5)   54,845 (7.6) 
0 episodes 8,231 (45.7)  338,205 (46.9) 
1 episode 4,984 (27.8)  200,745 (27.8) 
2 episodes 2,837 (15.7)  108,858 (15.0) 
3 episodes 1,280 (7.1)    49,887 (6.9) 
4 or more episodes    696 (3.9)    24,425 (3.4) 
Prevalent Clinical Malaria 3,123 (21.3) 3,375 (18.7) 149,622 (20.8) 
0 months 5,926 (32.9)  208,467 (28.9) 
1 month 3,458 (19.2)  136,778 (19.0) 
2 months 2,551 (14.2)  100,046 (13.9) 
3 months 1,988 (11.0)    82,299 (11.4) 
4 months 1,239 (6.9)    54,996 (7.6) 
5 months    931 (5.2)    42,461 (5.9) 
6 or more months 1,935 (10.7)    96,073 (13.3) 
Prevalent Parasitemia 9,488 (64.8) 3,375 (18.7) 464,366 (64.4) 
0 months 3,213 (17.8)    97,572 (13.5) 
1 month 2,058 (11.4)    76,999 (10.7) 
2 months 1,567 (8.7)    61,537 (8.5) 
3 months 1,332 (7.4)    52,148 (7.2) 
4 months 1,101 (6.1)    45,669 (6.3) 
5 months 1,057 (5.9)    41,009 (5.7) 
6 months    939 (5.2)    37,065 (5.1) 
7 months    816 (4.5)    33,498 (4.6) 
8 months    752 (4.2)    30,724 (4.3) 
9 months    677 (3.8)    27,872 (3.9) 
10 or more months 4,516 (25.1)  217,027 (30.1) 
Dry Season** 7,894 (43.8) 0 315,760 (43.8) 
Rainy Season** 8,170 (45.3) 0 326,800 (45.3) 
Transition Season** 1,964 (10.9) 0   78,560 (10.9) 
 $ Non-malarial anemia and illness were measured in the month prior to the exposure.  
# HAZ and WHZ were measured in the month after the exposure.  Imputed HAZ and WHZ values were not used in the final weighted 
outcome models – therefore HAZ and WHZ results are equivalent for both observed data and imputed data. Missing HAZ and WHZ data were 
accounted for through inverse probability of observation weights.   





The association between cumulative malaria and HAZ and WHZ varied with age, and 
was stronger in younger children. 
Height-for-Age Z-score outcome 
Cumulative episodes of incident clinical malaria, prevalent clinical malaria, and 
prevalent parasitemia were all associated with a decrease in mean HAZ among children under 
18 months (see Figure 15). 
The effect was strongest for cumulative episodes of incident clinical malaria, and weakest 
for cumulative episodes of parasitemia. In the incident clinical malaria model, a one episode 
increase in cumulative malaria was associated with -0.36 (95%CL: -0.43, -0.29) decline in mean 
HAZ among 3 month olds, -0.29 (-0.36, -0.23) for 6 month olds, and -0.16 (-0.22, -0.10) for 12 
month olds. In the prevalent parasitemia model the estimated decreases in mean HAZ were: -
0.14 (-0.15, -0.12) for 3 month olds, -0.11 (-0.13, -0.09) for 6 month olds, and -0.07 (-0.11, -
0.04) for 12 month olds. The estimates for prevalent clinical malaria fell between the incident 
clinical malaria and prevalent parasitemia estimates. Estimated associations according to the 
median number of cumulative malaria episodes demonstrated an attenuated effect by age for 
cumulative incident clinical malaria. However, the increased exposure to prevalent malaria 
(clinical or any parasitemia) was associated with a progressively larger decrease in HAZ through 
age 12 months (see Figure 15). The models also showed an estimated increase in mean HAZ 
among 30 month old children associated with an increase in all cumulative malaria exposures.  
The first graph in Figure 15 presents the estimated differences in mean HAZ associated with the 
median increase in each type of cumulative malaria (incident clinical malaria, prevalent clinical 






Median number of malaria episodes by age 
Age Incident Clinical Malaria Prevalent Clinical Malaria Prevalent Parasitemia 
3   0*   0* 1 
6   0* 1 3 
12 1 3 8 
18 1 4 10 
24 2 5 10 
30 2 6 10 
Figure 15: Estimated difference in mean Z-score associated with median number of episodes of cumulative malaria, 
by age.  Results are from inverse probability weighted, linear GEE models on imputed data. Models were weighted to 
control for time varying covariates, and final MI models controlled for age, mother’s education, sector of residence, 
maternal peripheral parasitemia, sickle cell genotype, and sex. Multiply imputed data did not include imputed HAZ or 
WHZ outcomes. N = 1,112 for HAZ outcome; N= 1,109 for WHZ outcome  




Weight-for-Height Z-score outcome 
A similar trend to the HAZ models was seen in the WHZ outcome models, although the 
estimates were closer to the null. The estimated difference in mean WHZ associated with a one 
episode increase in incident clinical malaria was -0.14 (-0.22, -0.05) for 3 month olds, -0.11       
(-0.19, -0.04) for 6 month olds, and -0.07 (-0.13, -0.01) for 12 month olds. For prevalent 
parasitemia the estimates were -0.03 (-0.05, -0.01) for 3 month olds, -0.02 (-0.04, 0.01) for 6 
month olds and 0.01 (-0.01, 0.04) for 12 month olds. The estimates for prevalent clinical malaria 
were again between the incident clinical malaria and prevalent parasitmia estimates. When 
graphed by the median number of cumulative malaria episodes, no additional trends were 
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evident. Despite fewer episodes, incident clinical malaria had the strongest association with 
subsequent WHZ. The WHZ outcome models also showed an increase in mean WHZ associated 
with an increase in prevalent clinical malaria and prevalent parasitemia among children 24 
months and older. The second graph in Figure 15 presents the estimated differences in mean 
WHZ associated with the median increase in each type of cumulative malaria, by age. 
 
Secondary Results 
The results from the available case analysis in the observed data closely mirrored the 
results from the weighted analysis on the imputed data. Modest differences in results were only 
seen in the model estimating the association between cumulative incident clinical malaria and 
WHZ, where the available case analysis was closer to the null. The estimated differences in mean 
WAZ associated with one episode increases in either cumulative incident clinical malaria or 
prevalent parasitemia largely fell in between the estimates for HAZ and WHZ. Figure 16 
presents the results from linear GEE models on observed data, estimating the difference in 
mean HAZ, WHZ or WAZ associated with a one episode increase in cumulative incident clinical 
malaria or prevalent parasitemia, by age. Note that Figure 16 is in a different format than Figure 
15. Figure 16 shows one graph for incident clinical malaria exposures, and one for prevalent 
parasitemia exposures. Within each graph in Figure 2 data are grouped by outcome (HAZ, WAZ, 
and WHZ), and presented estimates are for a one episode increase in cumulative malaria, rather 





Figure 16: Estimated difference in mean Z-score (HAZ, WAZ, and WHZ) associated with one episode increase in 
cumulative incident malaria or one month increase in cumulative prevalent parasitemia, by age. Estimates are from 
linear GEE models on observed data, adjusted for age, season, non-malarial infection, non-malarial anemia, residence 
sector, sickle cell genotype, maternal education, SES, and maternal peripheral parasitemia. 
 
Discussion 
Using data from the Asembo Bay Cohort Study in Western Kenya, we found a decrease in 
population mean HAZ and WAZ following a one episode increase in both cumulative clinical 
malaria and cumulative parasitemia among children under 18 months. A smaller association 
was seen between cumulative incident clinical malaria and WHZ, also among children under 18 
months. Incident clinical malaria infections had the largest initial effect on height and weight 
deficits in young children, but the strength of this effect decreased with age. Prevalent 
parasitemia and clinical malaria had more limited initial effects on HAZ, but these effects 
increased up through 12 months of age with an increase in the median number of months 
exposed to parasites. Effects of prevalent clinical malaria and any parasitemia on WHZ were 
more limited. 
A decrease in mean HAZ following malaria infection among young children is consistent 
with previous literature. More recent studies in Kenya found a decrease in HAZ ranging from -
0.4 to -0.8 associated with clinical malaria infection in children under 36 months,94 and an 
increased incidence rate of clinical malaria in the previous 6 months among both underweight 
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and stunted children under 2 years old, compared to well-nourished children.93 Two recent 
studies in Ghana also had similar findings among children 3 to 24 months old. The first showed 
a mean decrease in HAZ of -0.17 and -0.18 associated with at least one episode of parasitemia or 
clinical malaria, respectively.75 The second study found a 0.32 increase in risk of stunting 
associated with a one episode increase in clinical malaria.95  Our findings also demonstrate that 
in this population the association of cumulative malaria with subsequent nutritional status 
varied by age, and was only significant in children younger than 18 months. 
Modification of the association between malaria episodes and malnutrition by age has 
also been demonstrated by other studies. Two ITN intervention studies conducted on the same 
population after the completion of this study found a significant effect of the ITN intervention 
on HAZ, but not WHZ among children under 24 months,89 but no effect of the intervention on 
growth or nutritional status among children 5-12 years old. A study conducted on the coast of 
Kenya also found an elevated incidence of malaria among stunted and underweight children 
under the age of two, and a reduced incidence among children over age six.  A recent systematic 
review also highlighted that the effect of malaria on nutritional status is greatest in children 
under two.186 The age specific effect of malaria on malnutrition has previously been attributed to 
acquired immunity among older aged children,90 while others have hypothesized that age 
specific differences in the immune response to malaria or the timing of maximal linear growth 
in children contribute to this variation.93 In this population, prevalence of clinical malaria and 
high density infections peaked at 6-11 months, while parasitemia prevalence peaked from 12-35 
months. It is possible that the null association after 18 months of age is due to a combination of 
factors including both development of immunity to infection and malaria infection having a 
greater impact during a child’s highest period of growth. 
An increase in mean HAZ (and WHZ in the prevalent parasitemia models) associated 
with multiple malaria infections in 24 and 30 month olds is difficult to explain. This effect was 
also noted in seven year old children in a similar study on the Kenyan coast, with a much lower 
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intensity of malaria transmission.93 Children with any level of malaria parasitemia and 
documented fever in this study were treated with sulfadoxine/pyrimethamine (SP). Sulfadoxine 
is a broad spectrum sulfanilamide with both antibacterial and antimalarial properties. Children 
with a higher number of malaria episodes would have had a higher level of exposure to SP, 
which may have prevented other infections that could have led to poor growth, including 
diarrheal disease, respiratory infections, or pneumonia, all of which are associated with growth 
outcomes in children.21,78 
Children in our study also showed evidence of naturally acquired immunity (NAI) as 
early as one year of age, with an ability to limit the occurrence of high density infections.134 If 
increased malaria infections at younger ages resulted in stunted growth, then at older ages, 
shorter children may have been protected against clinical malaria while their taller counterparts 
had not yet developed NAI. Malaria exposures were accumulated over the entire duration of the 
study. Therefore, this hypothesis only holds if children who had delayed NAI then required 
additional episodes of malaria before developing immunity. Delayed immunity has previously 
been shown to lead to an increase in cumulative malaria episodes, when compared to children 
who developed immunity at a younger age.190  
Alternatively, this anomaly may be due to survivor bias as a result of differential survival 
with regards to the exposure and the outcome. Among children with more malaria episodes, the 
sickest, and potentially more malnourished children, may have been more likely to die. In this 
case, the remaining children with higher numbers of cumulative malaria episodes may have 
been taller or heavier (on average) than children with less malaria episodes. This study included 
209 children who died prior to the end of follow-up. Malaria incidence and nutrition status 
(HAZ, WAZ, WHZ) at last study visit were all associated with death. However, when deaths were 
accounted for through IPCWs, results were unchanged.There was a stronger association of 
cumulative malaria (both incident clinical malaria and prevalent parasitemia) with HAZ than 
WHZ or WAZ. Most previous research has shown limited or no effect of malaria on WHZ.  In 
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Nigeria, Oldenburg et al found multiple episodes of malaria infection during treatment for 
severe acute malnutrition did not affect WHZ at the end of follow-up.76 Other studies that have 
looked at the effect of p. falciparum malaria on subsequent WHZ also found no effect.74,84 There 
is some evidence that P. vivax malaria is associated with decreased WHZ or ponderal growth in 
children.74,92 Two intervention studies have also shown a positive effect of ITN use on weight 
gain, especially in young children.87,89  
Stunting represents a chronic condition, caused by long term insufficient nutrient intake 
and frequent infections that generally occurs before age two. Wasting is an acute manifestation 
of malnutrition resulting from significant food shortage or disease, and is a strong predictor of 
mortality.191 Underweight has generally been considered a composite of the two, representing a 
mix of children who are stunted and those who are wasted, although recent attention has been 
given to low WAZ as a strong predictor of children who are both wasted and stunted, indicating 
a greater risk of mortality.192 At the population level, stunting is generally associated with poor 
socioeconomic conditions and increased exposure to illness or inappropriate feeding practices. 
In this population, exposure to these conditions may have been exacerbated by multiple malaria 
infections, leading to a larger deficit in height gains, rather than in weight. Multiple malaria 
infections may have diverted nutrients toward fighting the infection, and away from growth 
promotion. Stunting in the absence of wasting is hypothesized to be the result of low intake or 
absorption of nutrients such as sulfur, phosphorous, calcium, magnesium, vitamins D, K and C 
and copper, which are required in higher amounts for skeletal growth than for other lean 
tissues.193  
While cumulative malaria showed a stronger association with stunting rather than 
wasting, it is important to contextualize this effect.  The largest estimate was a difference in 
mean HAZ of -0.36 resulting from a one episode increase in incident clinical malaria at three 
months old. Among males, a difference in HAZ of -0.36 at 3 months is equal to a difference in 
height of approximately 0.72cm.100 However, given that the effect was linear, two episodes of 
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malaria would result in twice the deficit in infants. Numerous severe infectious diseases in 
childhood have been shown to affect linear growth.21  Less severe forms of disease may also 
impair growth by suppressing appetite, reducing nutrient absorption, increasing nutrient losses 
and diverting nutrients to fight infection.78,79 Children who suffer a single bout of infection may 
recover without any significant loss of growth, or they may experience catch-up growth after 
recovery, provided they have an adequate nutritional intake and no immediate additional 
infections.79 However, children who experience multiple bouts of infection or persistent 
subclinical infection may be put into a state of continual growth suppression.78  While other 
infections such as diarrhea, pneumonia, measles and meningitis have been shown to impair 
growth,21 our research shows that in this population malaria had a limited effect on children’s 
growth. 
The cyclical nature of the interaction between malaria and malnutrition makes 
epidemiologic research on this topic challenging. Malnutrition may increase risk of malaria, 
while malaria may also increase risk of malnutrition. In this study the use of IPEWs to adjust for 
time varying confounding affected by prior exposure allowed for an estimation of the association 
between malaria and malnutrition while preventing potential reverse causality bias due to prior 
growth status. These methods are a particular strength of this study. The similarities between 
the available case analysis and the imputed, weighted models indicate that missing data and 
time varying confounding were not a large source of bias in this population.  
Our previous research (manuscript in preparation) demonstrated that while severe and 
mild stunting and moderate and mild underweight did not increase odds of new malaria 
infections in children under three, they did show an association with asymptomatic parasitemia. 
Conversely, the current study demonstrates that incident clinical malaria infections in young 
children may have an effect on height outcomes, while prevalent parasitemia shows less of an 
impact. Therefore while low HAZ does not necessarily predispose children to incident clinical 
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malaria infections, multiple incident clinical malaria infections may have a subsequent effect on 
children’s height. 
 
Strengths and Limitations 
This study had several strengths and limitations. Strengths included a large sample 
followed from birth with data on both clinical malaria and any parasitemia, monthly blood 
collections and anthropometric measurements, and the availability of a wide-ranging set of 
potential confounders to use in multivariable models. It has been estimated that 15 
measurements per child per year is sufficient to provide an unbiased estimate of the association 
between recurrent infections, such as malaria, and nutritional status.194 Although the dataset is 
older, the intensive follow-up of the population and the richness of the dataset make it an 
attractive vehicle for investigating the association of cumulative malaria with subsequent 
growth. The use of a longitudinal dataset and weighting methods to adjust for time varying 
confounding affected by prior exposure allowed us to isolate the effects of multiple malaria 
infections on growth, which otherwise would be difficult to determine without a potential for 
reverse causality bias.  
The age of the dataset may limit the generalizability of the study to current populations. 
If the current epidemiology of malaria in western Kenya is different than that experienced by the 
study population, this would make the results of this study less applicable to a current 
population. Malaria incidence in Kenya has decreased by 71.7/1,000 since 2000, while the 
prevalence of children sleeping under ITNs has increased by from 3% to 56%.180 Consideration 
should also be given to the differences in malaria treatment regimes between the study 
population (pre ACT) and current day populations, which are treated with ACT. Children in the 
study who presented with clinical symptoms and a positive blood film were treated with SP, but 
the only treatment available at local health facilities was chloroquine. In the mid-nineties there 
was some concern regarding treatment failures due to SP. However, children in the Asembo Bay 
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Cohort study were closely followed, and any known malaria treatment failures were treated with 
Halofantrine. Additionally, incident malaria infections were only counted if a child had no 
parasites in the previous month. These considerations should have minimized treatment failures 
and any potential differences in effectiveness of treatment between the study population and 
current day populations. 
The health and nutrition status of children under five has also improved over the past 25 
years. The prevalence of stunting in Kenya decreased 30% between 1998 and 2014. Optimal 
child feeding practices such as exclusive breastfeeding have also improved.30,182 It’s possible that 
the relationship between malaria and malnutrition has changed along with these improvements. 
Age patterns of malaria may have changed with improved intervention strategies – shifting the 
burden of infection to the right.195 Peak clinical malaria prevalence in this study occurred early, 
from 6-11 months, however a recent study in western Kenya showed that highest prevalence 
among hospital admissions from 2014 to 2016 was in 5-14 year olds.196 A shift to the right in the 
age distribution of malaria could result in a reduced association between cumulative malaria 
and population level nutrition outcomes because the majority of malaria infections may have 
occurred after major periods of growth had concluded (and after the majority of stunting has 
already occurred). Therefore malaria may currently have less of an impact on the growth status 
of children than it did during this study. However, given the recent decline in progress on 
malaria control2 it remains imperative to understand how a reversal in improvements against 
malaria may impact children, especially children under five, who remain most vulnerable to 
malaria infections. 
The high proportion of missing data in this study is a concern. Multiple imputation was 
used to account for missing data within completed visits and inverse probability weights were 
used to minimize bias due to completely missed visits and dropout. The benefit of these methods 
depends on whether the variables used in the weight and imputation models are sufficient to 
make the data missing at random. If there are unobserved variables that are associated with 
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missingness, and also associated with the exposure or the outcome, then selection bias may still 
be present. 
This study is missing data on HIV, a potential confounder. HIV may increase prevalence 
of clinical malaria in children115 or increase parasite density.183 If children with HIV were more 
likely to have malaria and be stunted or wasted, the effects may have been biased away from the 
null. However, confounding by HIV may have been partially controlled by other measured 
confounders (such as non-malarial infection, SES, or mother’s education), if they were also 
associated with HIV, conditional on the exposure.184 Additionally, previous research has 
demonstrated that the relationship between malnutrition and malaria does not change by HIV 
status.69 Given the potential for residual control of HIV by included covariates, and the lack of 
modification of the malnutrition-malaria relationship by HIV status, the results of this study are 
unlikely to be significantly biased by unmeasured confounding due to HIV. 
The analysis may also be subject to outcome measurement error. To calculate Z-scores 
children were assumed to have been measured recumbent until age two, and standing 
thereafter, yet the actual data collection procedures only indicated that children were measured 
standing if they could stand for the measurement. Height measurements used in the analysis 
were made one month after a child’s malaria assessment, making any measurement error likely 
to be nondifferential with regard to the exposure. 
 
Conclusions 
Multiple malaria infections may lead to consistent diversion and loss of nutrients, 
resulting in a decrease in subsequent mean height-for-age, weight-for-height, and weight-for-
age Z-scores among children under 18 months. This decrease in mean Z-score was not sustained 
at older ages, possibly as an artifact of survivor bias or confounding by treatment with SP, which 
was given for all symptomatic malaria infections. The modest height deficits shown in this study 
indicate that malaria is not a large driver of stunting, underweight or wasting in malaria 
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endemic areas. A further reduction in malaria incidence or parasitemia prevalence would not be 













CHAPTER 6: DISCUSSION AND CONCLUSIONS 
 
Summary of Results 
We used data from the ABCP to investigate the interaction between malnutrition and 
malaria in a cohort of young children followed from birth through 30 months in an intense 
malaria transmission area of western Kenya in the mid-nineties. The final sample included 
18,028 visits on 1,182 children who were followed from birth through 30 months of age. Mean 
age at enrollment was 5.4 days and average follow-up time was 16.4 months. Stunting was 
prevalent in this population, with a mean HAZ of -1.57. Underweight (mean WAZ = -0.45) and 
wasting (mean WHZ = 0.63) were less prevalent. Malaria in this community was endemic, and 
widespread prevention measures had not yet been implemented. Of the 1,182 children, 72% had 
at least one episode of clinical malaria and 79% had at least one episode of asymptomatic 
parasitemia during follow-up.  
The ABCP followed children from birth until five years of age, with visits occurring every 
two weeks. Blood draws and anthropometric measurements were taken every other visit (once 
per month). Although there was close follow-up of the study population, there was a large 
amount of missing data in this study – due to both completely missed visits and missing data 
within visits. To address the potential bias that may have been introduced due to missing data, 
we combined multiple imputation with inverse probability weighting in our analyses. This 
technique has been discussed in the literature, although its use is somewhat infrequent.111 
Multiple imputation was used to impute missing data within completed visits, while inverse 
probability weighting was used to account for completely missed visits. The inverse probability 
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weights rebalanced the dataset by upweighting individuals with similar characteristics to those 
who missed a particular visit. 
There was also a large amount of attrition in the ABCP. By age 30 months, approximately 
20% of the original sample was remaining. To account for bias that may have been introduced 
by loss to followup, we also calculated inverse probability of censoring weights. These weights 
rebalanced the dataset to approximate a population where no children dropped out, by 
upweighting children with similar characteristics to those who were lost to followup. 
Lastly, given the longitudinal nature of the analysis and the potential cyclical nature of 
the relationship between malaria and malnutrition, we also utilized inverse probability of 
exposure weights to account for time varying confounding affected by prior exposure. In each 
aim, this removed the association between the previous outcome and subsequent or concurrent 
exposure. All inverse probability weights were multiplied together to calculate a final weight for 
each child at each time point. The weights were well behaved with means close to one and a 
limited range (0.2-5.1). In both aims, results from the available case analysis on observed data 
were similar to results from the imputed/weighted analysis, indicating that missing data and 
time varying confounding by previous outcome did not bias the results significantly. 
In Aim 1 we investigated the association of malnutrition (HAZ, WAZ, and WHZ) with 
subsequent odds of malaria (both incident and prevalent clinical malaria and asymptomatic 
parasitemia). We found that severe and moderate stunting, and moderate and mild underweight 
were associated with increased odds of subsequent asymptomatic parasitemia. The prevalence 
odds ratio (POR) for the association between severe or moderate stunting (HAZ) and prevalent 
asymptomatic parasitemia in the following month was: severe = 1.35 (95% confidence limit 
(CL): 1.03, 1.76); moderate = 1.20 (95% CL: 0.95, 1.53). The POR for the association between 
moderate or mild WAZ and subsequent prevalent asymptomatic parasitemia was: moderate = 
1.35 (95% CL: 1.09, 1.66); mild = 1.16 (95% CL: 1.02, 1.33). The OR for the association between 
stunting and incident asymptomatic parasitemia was: severe = 1.31 (95% CL: 0.93, 1.85) and 
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moderate= 1.28 (95%CL: 0.95, 1.74). For underweight the OR for incident asymptomatic 
parasitemia was: moderate= 1.43 (95% CL: 1.05, 1.94) and mild=1.20 (95%CL: 0.98, 1.46). 
There was no association found between wasting and subsequent malaria infection 
(either prevalent or incident clinical malaria or asymptomatic parasitemia). Odds ratios for all 
WHZ models were close to 1. There was also no association found between any type of 
malnutrition and subsequent clinical malaria, whether incident or prevalent. All odds ratios for 
the association between each type of malnutrition and subsequent incident and prevalent 
clinical malaria were close to 1, with confidence intervals that crossed the null. 
In Aim 2 we investigated the association between cumulative malaria (both incident and 
prevalent clinical malaria, and prevalent parasitemia) and subsequent anthropometric Z-score 
(HAZ, WAZ and WHZ). We found that the association between cumulative malaria and 
subsequent Z-score varied with age – among children under 18 months cumulative malaria was 
associated with a decrease in mean Z-score, while in older children (24-30 months) cumulative 
malaria was associated with a modest increase in mean Z-score. The strongest association was 
seen between cumulative malaria and subsequent mean HAZ. All measures of cumulative 
malaria were associated with a decrease in mean HAZ among children under 18 months old. 
More modest associations were seen between cumulative malaria and subsequent mean WHZ - 
cumulative incident clinical malaria was associated with a decrease in mean WHZ among 
children under 18 months, but the association was closer to the null from the effect on HAZ. 
Cumulative months with prevalent clinical malaria or any parasitemia also showed an 
association with decreased mean WHZ, but only among children 6 months and younger. The 
effect of cumulative malaria on WAZ was only evaluated in the observed data, and these 






Interpretation of Findings 
This study demonstrated that there is a limited, modest interaction between 
malnutrition and malaria. Stunting and underweight may increase the risk of asymptomatic 
parasitemia, while cumulative episodes of incident malaria may result in a decrease in mean Z-
score.  
Overall, these results indicate that in this population malnutrition did not predispose 
children to increased odds of either incident or prevalent clinical malaria. Stunting and 
underweight did, however, show a limited association with odds of incident and prevalent 
asymptomatic parasitemia. Previous research has shown conflicting results regarding the effect 
of malnutrition on malaria, with some studies indicating that malnutrition predisposes children 
to malaria,15,45–49 some indicating no effect,46,50,59–62  and others indicating a protective 
effect.15,51,54–58 Our results from Aim 1 indicate that although stunting and underweight do not 
predispose children to increased risk of clinical malaria, such children do face a potential 
increased risk for asymptomatic parasitemia. This may indicate that once infected, underweight 
and stunted children may be less likely to develop a fever in response to malaria parasites than 
their non-malnourished counterparts. This may be due to a compromised immune response 
among malnourished children, including reduced TH1 cytokines and dendritic cells,177 or it may 
be due to immune exhaustion among malnourished children, which has been shown to mediate 
the host response to parasites, resulting in asymptomatic parasitemia.178 
Our results also indicated that although there was a limited association between stunting 
or underweight and asymptomatic parasitemia, there was no association between wasting and 
any form of malaria. A stronger effect for stunting, rather than wasting is largely consistent with 
a recent reviews on the topic, which found the largest number of studies (15 out of 23) indicating 
a significant association between stunting and malaria, but few indicating an association 
between wasting and malaria (only 3 of 18).186 Stunting represents a chronic condition which 
may have a different effect on the immune system than wasting, which is generally more 
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indicative of more recent, acute malnutrition. These results indicate that chronic malnutrition 
may have a greater impact on the immune response to malaria than acute malnutrition. 
Results from Aim 2 indicated that cumulative malaria was associated with a decrease in 
mean Z-score among the youngest children. This association was stronger for HAZ than WAZ 
and WHZ. Although the results were modest, they were precise and indicate that each additional 
episode of incident clinical malaria may have an additive, detrimental effect on children’s 
growth, especially linear growth. Although multiple incident malaria episodes among children 
under 18 months could have contributed to stunting in this population, children under 18 
months were more likely to have multiple months with prevalent infection (either any 
parasitemia or clinical malaria). By age 12 months, these prevalent infections were more likely to 
contribute to stunting than incident clinical malaria infections. Growth in the first two years of 
life is especially important, and linear deficits during this time are often permanent and may 
have lasting effects.21 Stunting in early childhood may result in poor cognitive and educational 
outcomes in adolescence.21 Malnutrition is caused by a variety of factors, including 
micronutrient deficiencies, poor complementary feeding practices, infectious disease, and 
maternal nutrition status.21 Malaria had some impact on child growth outcomes in this 
population, however it was one of a number of factors that would have contributed to 
malnutrition. Given the scale-up of malaria interventions and preventative measures since the 
time of the ABCP, it is likely that malaria plays less of a role in growth outcomes among children 
today. 
In Aim 2 we also found an increase in HAZ and a limited increase in WAZ associated 
with multiple malaria infections in children 24-30 months old. This was an unexpected finding 
that may be due to treatment with SP (which may have had a prophylactic effect on other 




Previous research studies on the interaction between malnutrition and malaria have 
shown heterogenous results, some of which are unexpected. Likewise, in our study we found 
that malnutrition was not associated with subsequent clinical malaria, but it was associated with 
subsequent asymptomatic parasitemia. Also, while cumulative malaria had a detrimental effect 
on growth at the youngest ages, by age 24 months this effect seemed to reverse.  The 
relationship between malaria and malnutrition in children is complex and dependent on a 
number of factors. The type of malnutrition (HAZ, WAZ, or WHZ), its various causes 
(micronutrient deficiencies, poor diet, other infections, and fetal exposures) and the age of the 
child may all have an effect on a child’s immune system, altering how a child responds to 
malaria infection. Likewise, the epidemiology of malaria also plays a role in determining how 
malaria and malnutrition interact. Intensity of transmission, development of naturally acquired 
immunity, effectiveness of treatment, and use of preventive measures may all affect interactions 
with the child’s immune system, and any potential loss or diversion of nutrients that may occur 
to fight the infection. The interplay of these factors likely determines the heterogeneity seen in 
previous studies, and may have had an impact on the findings from this study. 
 The use of inverse probability of exposure weights to prevent time varying confounding 
affected by prior exposure and reverse causality bias was a novel approach of this study, which 
has not previously been used to investigate the relationship between malnutrition and malaria. 
The agreement of the unweighted, observed data analysis with the weighted, imputed data 
analysis indicates that the relationship between malaria and malnutrition was not biased by 
reverse causality, or the missing data in this study. There has only been one other study to use a 
novel approach to prevent reverse causality bias. Kang et al. used sickle cell trait as an indicator 
variable to control for confounding of the relationship between cumulative malaria and 
subsequent HAZ.  Their results were similar to our Aim 2 results, indicating that for every 
episode increase in malaria from 3 months to 2 years, there was a 0.32 increase in risk of 
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stunting at 2 years old. To our knowledge, no other studies have used an innovative approach to 
prevent reverse causality bias in the estimation of the effect of malnutrition on malaria risk. 
 
Strengths and Limitations 
Strengths of this study include the use of a rich dataset on a large sample of children 
followed regularly from birth with data on both clinical malaria and asymptomatic infections. 
The study included a wide ranging set of potential confounders to use in the multivariable 
models. The higher incidence of malaria that occurred during the study period most likely 
provided this study with greater power to detect effects than that of a current day study, where 
incidence of malaria would be lower. 
Aside from the higher incidence of malaria, the age of the dataset is a limitation of this 
study. The current epidemiology of malaria in western Kenya is different than that experienced 
by this cohort. Any associations reported in this study may not necessarily represent 
associations that currently exist in western Kenya given that relationship between malaria and 
nutrition is likely influenced by the specific epidemiology of malaria and determinants of 
malnutrition. As described previously, the incidence of malaria has decreased over the past 20 
years with the introduction of preventive measures and improved access to treatment. 
Additionally, differences in treatment effectiveness may make the findings less generalizable to 
current populations. The ABCP study protocol called for treatment with SP for clinical malaria 
infection, and referral to local health centers for severe disease where the standard malaria 
treatment was chloroquine. There was definitely chloroquine resistance in Kenya at this time, 
which was replaced as the standard treatment for Kenya in 1998.144 There is concern that the 
parasite may have begun to show some resistance to SP in the 1990s as well.144 However, all 
children in the study were regularly evaluated for malaria and treated with SP. In early 1993 the 
study protocol called for additional treatment with Halofantrine if a treatment failure was 
identified. The close follow up of participants, prompt treatment, and protocol for treatment 
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failures should ensure that all children in the study were treated adequately for malaria, while 
minimizing and managing any treatment failures. If there was some resistance to SP at this 
time, the additional treatment and close follow up would have mitigated this issue. Additionally, 
the requirement that a child’s previous record be negative for parasites reduced the possibility 
that recrudescent malaria was considered as an incident infection.  
Children’s nutrition status in Kenya has also improved over the past 25 years. Prevalence 
of stunting has decreased and optimal child feeding practices have increased.30,182 It is likely that 
other determinants of malnutrition, such as water and sanitation, and exposure to other 
infections, have also improved. Advances in the prevention of malnutrition and changes to the 
proximal determinants of malnutrition may alter modulation of the immune system by 
malnutrition, subsequently changing how malnutrition affects susceptibility and response to 
malaria infection. 
There were a number of potential sources of bias in this study, including selection bias 
due to censoring or missed visits, measurement error, and confounding bias due to unmeasured 
confounders. Left censoring was negligible because mothers were enrolled before their infant’s 
birth, and infants were then followed from birth. However, 20% of the original sample was lost 
to follow-up by the age of 30 months indicating a potential for bias due dropout. Missed visits 
were another potential source of bias, with approximately 40% of visits either completely missed 
or missing outcome data. The use of inverse probability of censoring weights and inverse 
probability of observation weights to rebalance the sample should have minimized these 
potential biases. Missing data within completed visits was yet another potential source of bias, 
which was accounted for through multiple imputation. By using a combination of inverse 
probability weights and multiple imputation we limited the number of records that were 
imputed (because only records within kept visits were imputed), while also improving the 
weight calculations - weight calculations were performed after multiple imputation, allowing the 
use of a complete dataset for all kept visits. 
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Confounding bias is another potential source of error in this study. Although we adjusted 
for a number of potential confounders identified through a DAG analysis, we were missing 
information on HIV status, iron deficiency and breastfeeding, and could not control for SP 
treatment. Given that HIV may increase prevalence or severity of malaria, and increase 
malnutrition, results may have been biased away from the null. The degree of bias expected 
from unmeasured HIV was estimated in Chapter 3. However, confounding bias due to HIV may 
have been partially controlled by other measured confounders associated with HIV, such as non-
malarial infection, SES, or mother’s education.184 Additionally, the relationship between 
stunting and malaria has previously been shown to be consistent across HIV infected and 
uninfected children.69 Considering the independence of the malnutrition-malaria relationship 
from HIV status and the potential for residual control of HIV by other covariates, the results of 
this study are unlikely to be significantly biased by unmeasured HIV status. 
Another source of unmeasured confounding was iron deficiency. Iron deficiency is 
protective against malaria, and may be associated with malnutrition.32,146,147 We used low 
hemoglobin as a proxy for iron deficiency anemia. Low hemoglobin can be caused by iron 
deficiency, but also by various infections and other nutritional deficiencies. Therefore low 
hemoglobin is not an ideal proxy for iron deficiency. However, we increased the specificity of 
low hemoglobin as a marker for iron deficiency by excluding anemia caused by malaria. Given 
that most previous studies on this topic have not adjusted for iron deficiency, the use of a proxy 
variable is an improvement from previous research. 
A third unmeasured potential confounder was breastfeeding status. Exclusively breastfed 
children may be protected against clinical malaria.197 However, there is not strong evidence to 
indicate that exclusive breastfeeding results in better growth outcomes.198,199 At the time of this 
study the median duration of exclusive breastfeeding in western Kenya was only 0.7 months,200 
and breastfeeding practices were most likely homogenous across the study population. Given 
these factors it is unlikely that the results were significantly biased by breastfeeding status. 
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A final potential source of confounding bias that could not be controlled for was 
treatment with SP. All children with symptomatic malaria were treated with SP, which may have 
prevented other infections that could also cause growth faltering. While we adjusted for non-
malarial illness in all models, this may not have been sufficient to address potential confounding 
by treatment with SP. We could not directly adjust for SP treatment because it was so closely 
tied to malaria infection, which was either the exposure or the outcome in our models. 
Measurement error due to height mismeasurement and Z-score calculations is another 
potential source of bias. Implausible Z-scores were discarded per WHO recommendations, and 
heights were also visually inspected as described in Chapters 3, 4 and 5. This should have 
minimized measurement error with regard to height. However, when calculating Z-scores, 
children were assumed to have been measured recumbent until age two, and standing 
thereafter. The data collection procedures only indicated that children were measured standing 
if they could stand for the measurement. Z-scores based on height that were used in the analysis 
were made either one month before (Aim 1) or after (Aim 2) a child’s malaria assessment, 
making any potential height or Z-score measurement errors likely to be non-differential with 
regards to malaria. 
 
Public Health Significance and Future Research Directions 
Our research has shown that malaria and malnutrition had a limited interaction in this 
high transmission setting with limited malaria interventions in place. Malnutrition plays a small 
role in susceptibility to asymptomatic parasitemia in children under three years. Likewise, 
malaria has a limited effect on the development of stunting, underweight and wasting among 
children under three. Although the effect estimates were modest, there are some significant 
takeaways from this research. 
 We have shown that stunted and underweight children have increased odds for 
asymptomatic parasitemia. Given the recent stalling of progress on malaria control, and the 
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global health community’s continued long term goal for malaria elimination, it is important to 
determine which groups may be at increased risk for asymptomatic parasitemia, as these 
infections may still transmit malaria but can also go largely undetected.2,18 Underweight and 
stunted children may not present with symptoms, yet they may be at increased risk for malaria 
infections. A test and treat strategy should be considered for stunted and underweight children 
during growth monitoring.  
Our second aim showed that young children in high intensity transmission areas are 
likely to suffer some growth deficits as a result of multiple malaria infections.  Although progress 
has been made over the past 25 years, stunting remains a major issue for children under five, 
especially in malaria endemic areas. Therefore countries should remain vigilant about 
promotion of prevention measures such as ITNs among young children in endemic areas, and all 
infections should be treated promptly. 
This research raised some interesting questions that could be considered for future 
research. Aim 1 demonstrated that underweight and stunted children had higher odds of 
asymptomatic parasitemia, while this effect was not seen for clinical malaria. There has been 
limited research on the effect of malnutrition on asymptomatic parasitemia and on how 
malnutrition may affect the immune system. These are both areas for potential future research. 
Aim 2 demonstrated that the effect of cumulative malaria on malnutrition varies with 
age, and actually reverses after 24 months. A number of other studies have shown a positive 
association between malaria and growth, and to our knowledge no explanation has ever been 
offered for this paradoxical association. In this study it may be related to treatment with SP, the 
specific age of naturally acquired immunity, survivor bias, or some other bias. This is also an 







In this malaria endemic setting with few malaria preventative measures there was a 
limited bidirectional relationship between malnutrition and malaria among children under three 
years. Although malaria and malnutrition did show an association, the impact of one on the 
other was limited. Given the improvements that have been made in both malaria and 
malnutrition prevention, it is likely that current associations between these two morbidities is 
even more limited. Practitioners should be aware that malnourished children may be at higher 
risk for asymptomatic parasitemia, and that multiple malaria infections in young children may 
lead to growth deficits. However it is unlikely that an improvement in one would have a large 
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